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1 SUMMARY 
Introduction: The adult mammalian brain retains neural stem cells (NSCs) that contin-
ually generate new neurons within two restricted regions, the subventricular zone 
(SVZ) of the lateral ventricle and the subgranular zone (SGZ) of the dentate gyrus in 
the hippocampus (HC). This process is called adult neurogenesis. Controlled stimula-
tion of endogenous neurogenesis might be an elegant way to treat neurodegenerative 
diseases. It is therefore important to understand the molecular signals, which govern 
the proliferation, migration, and differentiation of endogenous NSCs in the neurogenic 
niches. Regulatory mechanisms in the so-called neurogenic niches have already been 
shown by in vivo studies for various factors, including numerous neurotransmitters, and 
behavioral and environmental factors. However, our knowledge is still insufficient to 
exploit adult neurogenesis for controlled brain repair or for stimulation of its physiologi-
cal function.  
The sleep disorder narcolepsy is considered to be a neurodegenerative disease be-
cause there is a massive progressive loss of neurons containing the neuropeptide 
orexin. Consequently narcoleptic patients have very low cerebrospinal fluid levels of 
orexin. Narcolepsy is defined as a sleep-wake disorder with REM and non-REM sleep 
associated symptoms existing longer than 6 months, such as daytime sleepiness, cat-
aplexy, fractionated sleep at night and automatic behaviors. The postulated pathophys-
iology of human narcolepsy is mimicked very closely in a transgenic mouse model 
called orexin/ataxin-3 mouse, in which orexin-containing neurons are ablated progres-
sively by specific overexpression of a truncated cytotoxic ataxin-3 gene product under 
the orexin-promoter.  
Aim: We aimed to study the possible role of the protein orexin in the regulation of adult 
neurogenesis in the orexin/ataxin-3 mouse. 
Study design: Adult neurogenesis in the SGZ, SVZ and rostral migratory stream 
(RMS), where the cells migrate from the SVZ to the olfactory bulb (OB), was studied by 
immunohistology. For the evaluation of the stem cell proliferation in SVZ and SGZ and 
migration in the RMS, orexin/ataxin-3 mice (n = 8) and wild type (WT) mice (n = 8) re-
ceived a single intraperitoneal injection of 100 mg BrdU (bromodeoxyuridine)/kg body 
weight 2 hour prior to sacrifice. For the analysis of differentiation and survival of newly 
built cells, BrdU was administered intraperitoneally on 5 consecutive days once per day  
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to orexin/ataxin-3 mice (n = 8) and WT mice (n = 8) and they were sacrificed 30 days 
after the last injection.  
Results: We found a significantly higher proliferation of stem/precursor cells in the 
orexin/ataxin-3 mice in both neurogenic regions, the SGZ and the SVZ. Also in the 
RMS, higher levels of newly built cells in the orexin/ataxin group were found, but these 
differences were not significant.  
We were able to demonstrate a significantly higher survival of newly built cells in the 
granular zone, but not for the periglomerular zone of the OB in the orexin/ataxin group. 
A tendency for higher survival rates could be shown for the HC of the orexin/ataxin-3 
mice (not significant).   
By triple staining we could show that the proportion of newly born neurons relative to 
the total number of newly built cells in the HC was significantly higher with 90 % in the 
orexin-ataxin group compared to 83 % in the control group. In both the granular zone 
and the periglomerular zone of the OB, over 90 % of the total amount of new built cells 
differentiated into neurons in both groups. Also the rate of differentiation into a dopa-
minergic phenotype of the newly born neurons in the periglomerular zone of the OB 
was not significantly changed with 93 % in the orexin/ataxin-3 mice compared to 91 % 
in the WT mice. 
Conclusion: In the absence of orexin in the adult mouse brain, the proliferation of 
adult neural stem/precursor cells was increased, the survival rate was significantly in-
creased in the granular zone of the OB and a consistent not significant trend was seen 
in the HC. The proportion of newborn neurons among all newly born cells was higher in 
the HC, however, no significant differences in the differentiation of newly built cells 
could be found in the OB. Together, these observations lead to the assumption that 
orexin suppresses the proliferation of adult NSC, affects the survival rate in the OB 
negatively and hinders the differentiation of newly built cells into neurons in the HC.
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2 ZUSAMMENFASSUNG 
Einleitung: Im adulten Gehirn von Säugetieren gibt es zwei Hirnregionen, die sub-
ventrikuläre Zone (SVZ) des lateralen Ventrikels und die subgranuläre Zone (SGZ) im 
Gyrus dentatus des Hippocampus (HC), in denen durch Stammzellteilung ständig neue 
Nervenzellen entstehen. Dies wird als adulte Neurogenese bezeichnet. Die kontrollierte 
Stimulation der adulten Neurogenese könnte als ein endogener Reparaturmechanis-
mus genutzt werden um neurodegenerative Erkrankungen zu behandeln. Es ist daher 
wichtig molekulare Signale, welche die Proliferation, Migration und Differenzierung en-
dogener neuronaler Stammzellen in den neurogenen Zonen beeinflussen, besser zu 
verstehen. Regulationseffekte der sogenannten neurogenen Nische wurden bereits für 
verschiedene Faktoren, v.a. für zahlreiche Neurotransmitter nachgewiesen. Allerdings 
ist unser Wissen noch nicht ausreichend, um die adulte Neurogenese für die Reparati-
on von degeneriertem Nervengewebe gezielt einzusetzen.  
Narkolepsie gilt als eine neurodegenerative Erkrankung, die mit einem massiven Ver-
lust von Orexinneuronen und einem stark vermindertem Orexin-Spiegel im Liquor ein-
hergeht. Dies führt unter Anderem zu einer Störung der Schlaf-Wach-Regulation. Das 
hier verwendete transgene Orexin/Ataxin-3 Mausmodell kommt der vermuteten Patho-
physiologie der Narkolepsie sehr nahe. Die spezifische Expression des zytotoxischen 
Ataxin-3 Genprodukts unter der Kontrolle des Orexin Promoters führt zu einem progre-
dienten Untergang der orexinergen Neurone.  
Ziel: Ziel der Arbeit war es, den Einfluss von Orexin auf die adulte Neurogenese in 
dem Orexin/Ataxin-3 Mausmodell zu untersuchen.  
Versuchsanordnung: Die adulte Neurogenese wurde im Bulbus olfactorius (OB), dem 
rostralen migratorischen Strom (RMS), in der SVZ und im HC immunhistologisch un-
tersucht. Für die Untersuchung der Stammzellproliferation in der SGZ und SVZ und der 
Migration im RMS erhielten gesunde Wildtyp Mäuse und Orexin/Ataxin-3 Mäuse (n=8 
pro Gruppe) einmalig eine intraperitoneale Injektion von 100mg BrdU (Bromodeoxyuri-
dine)/kg Körpergewicht 2 Stunden bevor sie getötet wurden. Zur Untersuchung der 
Differenzierung und der Überlebensrate der neu gebildeten Zellen wurde jeder Maus 
BrdU als intraperitoneale Injektion an 5 aufeinander folgenden Tagen verabreicht (n=8 
pro Gruppe) und die Versuchstiere wurden 30 Tage nach der letzten Injektion getötet.  
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Ergebnisse: In den Orexin/Ataxin-3 Mäusen fanden wir eine signifikant höhere Prolife-
rationsrate der Stammzellen in beiden neurogenen Zonen, der SGZ und der SVZ. Auch 
im RMS, in welchem die neu gebildeten Zellen aus der SVZ in den OB wandern, wurde 
eine tendenziell höhere Anzahl BrdU markierter Zellen in der Orexin/Ataxin-3 Gruppe 
gefunden (nicht signifikant). Zudem wurde im zweiten Versuchsteil eine tendenziell 
höhere Überlebensrate neu gebildeter Zellen im HC der Orexin/Ataxin-3 Mäuse sicht-
bar (nicht signifikant). Für die granuläre Zone des OB konnten wir dagegen eine signifi-
kant höhere Überlebensrate in der Orexin/Ataxin-3 Gruppe zeigen. In der periglome-
rulären Zone des OB fanden wir keinen Unterschied in der Überlebensrate. Der Ein-
fluss der Orexin-Defizienz auf die Differenzierung der Neurone wurde durch eine Fluo-
reszenz-markierte Dreifachfärbung untersucht. Hier konnten wir zeigen, dass die neu-
ronale Differenzierung der neugeborenen Zellen im HC mit 90 % in der Orexin/Ataxin-3 
Gruppe signifikant höher war als in der Kontrollgruppe mit nur 83 %. In der granulären 
und periglomerulären Zone des OB konnte kein signifikanter Unterschied in der neuro-
nalen Differenzierungsrate gefunden werden (jeweils > 90 %). Die dopaminerge Diffe-
renzierungsrate in der periglomerulären Zone des OB zeigte sich mit 93 % in der 
Orexin/Ataxin-3 Gruppe gegenüber 91 % bei den Wildtyp-Mäusen ebenso nicht signifi-
kant erhöht.  
Interpretation: Hieraus kann geschlossen werden, dass im adulten Mäusegehirn in 
der Abwesenheit von Orexin die Proliferation der adulten neuronalen Stammzellen in 
der SVZ und SGZ gesteigert war. Zudem war die Überlebensrate der neugeborenen 
Zellen in der granulären Zone des OB signifikant erhöht. Im HC konnte dagegen kein 
signifikanter Unterschied in der Überlebensrate gezeigt werden. Für die neuronale Dif-
ferenzierung konnte ein signifikanter Unterschied für den HC, nicht jedoch für den OB 
nachgewiesen werden. Die Ergebnisse führen zu der Annahme, dass Orexin die 
Proliferation der adulten neuronalen Stammzellen unterdrückt, sich auf die Überlebens-
rate der neu gebildeten Zellen im OB negativ auswirkt und die neuronale Differenzie-
rung im HC erschwert. 
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3 INTRODUCTION 
3.1 Adult neurogenesis 
In the last century, research in the field of neuroscience was determined by a central 
paradigm on neurons in the central nervous system: "Everything may die, nothing may 
be regenerated". Ramon y Cajal postulated this phrase in his publication in 1928 "De-
generation and regeneration of the nervous system”. This paradigm found great ac-
ceptance in the neuroscientific community for a long time. Thereafter, it was assumed 
that all neurons in the human central nervous system were generated during embryonic 
and early postnatal development. Due to its complexity and specialization, the neural 
network of the adult brain was thought to be a fixed structure and its function was not 
compatible with the idea of adult neurogenesis (Brandt and Storch, 2008). Early reports 
of neurogenesis in the adult central nervous system (Allen, 1912, Levi, 1898) were ig-
nored, because technical capabilities of cell labeling to identify mitotic cells as neurons 
were not yet developed. Five decades later, the technical possibilities were extended, 
allowing Joseph Altman to demonstrate that cells of the hippocampus (HC) (Altman 
and Das, 1965) and in the olfactory bulb (OB) (Altman, 1969) of the rat incorporate 
radio-labeled thymidine. Thus, he provided first evidence of cell proliferation in this re-
gion. Kaplan and Hints (1977) could first show by electron microscopy that these newly 
built cells in the adult brain are actually neurons. Further support on the way to a para-
digm shift and acceptance of the concept of adult neurogenesis in higher vertebrates 
yielded the discovery of neurogenesis in birds in connection with the occurrence of 
seasonal song (Nottebohm, 1989). The breakthrough and international acceptance of 
the phenomenon of adult neurogenesis occurred with the demonstration that newly 
derived neurons in the adult mammalian brain can migrate and integrate into existing 
circuitries (Gross, 2000). This possibility was given by the development of new meth-
ods, such as the exogenously supplied bromodeoxyuridine (BrdU). BrdU is a synthetic 
analogue of thymidine that is incorporated in the cellular DNA of proliferating cells in 
the S phase of mitosis and can be subsequently detected by immunohistochemistry. 
This was the first opportunity to undertake detailed quantitative and qualitative anal-
yses of adult-generated cells in the brain (Gage, 2000, Kempermann et al., 2004b). 
Since then a lot of research was done concerning regulation and function of adult neu-
rogenesis. 
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3.1.1 Regions of adult neurogenesis 
There are two regions in the adult mammalian brain where adult neurogenesis occurs: 
in the subventricular zone (SVZ) of the lateral ventricles and in the subgranular zone 
(SGZ) of the dentate gyrus in the HC. Progenitor cells in the SVZ proliferate and form 
neurons that migrate along the so-called rostral migratory stream (RMS) into the OB. 
New granule cells, formed in the SGZ in the HC, get functionally integrated into the 
existing hippocampal neuronal network.  
Neural stem cells (NSC) or precursor cells, differentiating to glial cells and neurons in 
vitro or after transplantation could also be isolated from other areas of the adult brain 
(Palmer et al., 1995, Palmer et al., 1999, Hermann et al., 2006b). Under physiological 
conditions these NSC seem to rest, hindered from proliferation and differentiation by 
their microenvironment. These observations confirm the theory that the two neurogenic 
regions of the brain are distinguished from non-neurogenic regions by their stem and 
progenitor cell-friendly environment providing proliferation, differentiation and integra-
tion of new neurons (Alvarez-Buylla and Lim, 2004, Palmer et al., 2000).This specific 
microenvironment of SGZ and SVZ is also known as the “neurogenic niche” (Doetsch, 
2003, Zhao et al., 2008). 
The SVZ is localized along the lateral wall of the lateral ventricles and corresponds to a 
residual of the embryonic ganglionic eminence which retains the ability to reconstitute 
neuronal and glial cells until adolescence (Lois and Alvarez-Buylla, 1993, Parnavelas, 
2000). This thin cell layer lies next to the ependyma and is thereby also called subep-
endyma. Initially, the ependymal cells were thought to be adult NSC and thus respon-
sible for adult neurogenesis in the SVZ (Johansson et al., 1999). Later it was shown 
that these cells do not possess the capabilities of NSC. Instead other cells, which have 
structural and molecular characteristics of astrocytes, such as expression of the glial 
fibrillary acid protein (GFAP), were shown to function as primary precursors (Doetsch 
et al., 1999a). According to a lineage model, these multipotent neural progenitors (type 
B cells) produce clusters of transit amplifying progenitor cells (type C cells), which in 
turn generate the neuronal progenitor cells also called neuroblasts (type A cells) by 
asymmetric cell division (Alvarez-Buylla and Lim, 2004, Doetsch et al., 1999a, Doetsch 
and Alvarez-Buylla, 1996). Because type B cells are mitotically relatively quiescent 
(Doetsch et al., 1999a), their identification was mainly based on morphological analysis 
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by electron microscopy. Type C and A cells in turn can also be identified by immun-
histochemical methods such as cell labeling with BrdU (Zhao et al., 2008).  
The neural progenitor cells, neuroblasts or type A cells, migrate along the RMS into 
the OB (Fig 1). Only after reaching their final destination, the precursor cells differenti-
ate into neurons, more precisely into periglomerular or glomerular interneurons, and 
get functionally integrated (Carleton et al., 2003, Gritti et al., 2002, Doetsch et al., 
1999b). The majority of new neurons is sorted out by apoptosis before their functional 
integration (Kaplan and Hinds, 1977). 99 % of the surviving cells migrate towards the 
granule cell layer, only 1 % into the glomerular layer. Almost all granule cells are GA-
BAergic (gamma-aminobutyric acid = GABA) (Mugnaini et al., 1984). The percentage 
of new periglomerular cells turning into dopaminergic phenotype is about 30 % in the 
adult (Winner et al., 2002) compared to 10 % in the neonatal OB (Betarbet et al., 
1996).  
 
Fig. 1 : Schematic illustration of the rodent OB structure and its connections. The OB is divided 
into six main layers: (i) the glomerular layer, (ii) the external plexiform layer, (iii) the mitral cell 
layer, (iv) the internal plexiform cell layer, (v) the granule cell layer, and (vi) the RMS at the 
core. The OB receives inputs from olfactory sensory neurons (OSN) and from centrifugal fibers. 
The OB output is provided by mitral/tufted cells, and these project to several parts of the olfacto-
ry cortex. OSN project axons to glomeruli (white disks), where they activate mitral/tufted cells 
and periglomerular cells. Centrifugal inputs modulate periglomerular and granule cell activities, 
and these in turn modulate mitral cell activity. Taken from (Lazarini and Lledo, 2011). 
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Neurons born in the SGZ migrate into the granule cell layer of the dentate gyrus and 
become dentate granule cells (Zhao et al., 2008). As in the SVZ, GFAP-positive astro-
cytes are also seen as stem cells of adult hippocampal neurogenesis in the SGZ 
(Gage, 2000). Three subtypes of SGZ cells can be distinguished. According to their 
specific morphologies and molecular markers two types of neuronal progenitors could 
be identified. Type 1 cells are radial-glia like cells. They express the astrocytic marker 
GFAP and share several other astrocytic features such as vascular end-feet and typical 
electrophysiological properties (Kempermann et al., 2004a). Furthermore, they express 
nestin and the transcription factor Sox2 (Fukuda et al., 2003, Garcia et al., 2004, Suh 
et al., 2007). Type 2 cells do not express GFAP but Sox2 and were thought to be the 
transiently amplifying progenitor cells in the neuronal lineage and would arise from 
type 1 cells (Kempermann et al., 2004a). However Suh et al. demonstrated that type 2 
cells itself also show stem cell characteristics like the capacity for self-renewal and 
ability to give rise to neurons and astrocytes (Suh et al., 2007) and thereby challenge 
the concept of a lineage relationship. The transcription factor Sox2, which is expressed 
by type 1 and type 2 cells, seems to be an essential property of neuronal stem cells 
(Zhao et al., 2008). GABAergic synaptic contacts reach type 2 cells. GABA acts excit-
atory on these cells and stimulates the maturation (Tozuka et al., 2005, Wang et al., 
2005). Type 3 cells correspond to the so-called neuroblasts, which have only a low 
proliferation rate. The exclusive expression of neuronal proteins and the absence of 
glial immunohistochemical characteristics suggest that these cells are already deter-
mined on a neuronal phenotype. This stage is characterized by morphological change 
due to the incipient arborisation and migration into the granule cell layer (Plumpe et al., 
2006, Rao and Shetty, 2004). Similar to the embryonic and early postnatal neurogene-
sis much more immature neurons are formed during the proliferation phase, as ulti-
mately will be integrated in the neural network (Kuhn et al., 2005, Biebl et al., 2000).  
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Fig. 2 Location and structure of neurogenic zones in the brain (with kind permission from Oscar 
Arias-Carrión). 
a) Sagittal section through an adult mouse brain: The neuroblasts, built in the SVZ (box A) mi-
grate along the RMS into the OB and differentiate there in interneurons. The newly built cells 
from the SGZ (box C) migrate only a short distance into the granular cell- layer of the dentate 
gyrus within the HC. 
b) Cellular composition of the SVZ: The multipotent stem cells of the SVZ, called type B-cells 
(B) produce the highly proliferating type C-cells (C) from which the neuroblasts (type A-cells) 
emerge. The cells of the SVZ are demarcated by the ventricular system through the cells of the 
ependymal layer (type E-cells). 
c) Cellular composition of the SGZ: From multipotent stem cells, called type 1 cells (1), arise 
type 2 cells (2). Type 3 cells (3) correspond to the so-called neuroblasts, which have only a 
low proliferation and differentiate into neurons of the granular cell layer. 
3.1.2 Regulation of adult neurogenesis 
The regulation of adult neurogenesis can be considered at different levels. First of all, 
the influence on adult neurogenesis by changes of behavior and environmental stimuli 
shall be displayed. This will be illustrated by means of examples like the influence of 
activity, sleep, stress and changes in odor or other environmental stimuli. Thereafter, 
on the level of microenvironment, also known as "the neurogenic niche", the role of 
cell-cell interaction between astrocytes and progenitor cells, selected molecular signals 
and the importance of structures such as blood vessels will be shown. Finally, the in-
fluence of neurotransmitters will be explained in detail. Since a lot of research concern-
ing regulation of adult neurogenesis has been done in recent years, this chapter will 
only describe selected influences on the different levels. 
INTRODUCTION	
	
	
	 	 	
12	
Influence of behavior and environment 
In 1997, Kempermann et al. have shown that significantly more new neurons exist in 
the dentate gyrus of mice exposed to an enriched environment (large cages equipped 
with paper tubes, nesting material, a rearrangeable set of plastic tubes, a running 
wheel etc.) compared to littermates housed in standard cages (Kempermann et al., 
1997). However, environmental enrichment appears to have no effect on adult neuro-
genesis in the OB (Brown et al., 2003). But opposite results have been found for olfac-
tory enrichment (Rochefort et al., 2002). Using a combination of immunohistological 
and behavioral approaches it was shown that an odor-enriched environment enhances 
the bulbar interneuron population and improves olfactory memory without up-regulating 
hippocampal neurogenesis. Different natural odors (lavender, garlic, paprika etc.) were 
used to enrich the olfactory environment. Experiencing an enriched environment can 
be seen as a form of continued learning. Implying, that complexity and novelty are key 
stimuli for adult neurogenesis (Kempermann, 2002, Kempermann et al., 2004b, 
Kempermann, 2011). Physical activity is a potent inducer of adult neurogenesis in par-
ticular. It leads to increased proliferation and differentiation of progenitor cells and pro-
longed survival of newly built cells (van Praag et al., 1999, van Praag et al., 2005, 
Kempermann, 2011).  
Stress is a potent negative regulator on adult neurogenesis. In 1994 cortisol was al-
ready known as an important stress hormone, when Cameron and Gould showed that 
adrenalectomy leads to up-regulation, whereas exogenous glucocorticoid has down-
regulation of adult hippocampal neurogenesis (Cameron and Gould, 1994). Prolonged 
sleep deprivation decreases adult neurogenesis in the HC and is considered to be 
stressful (Guzman-Marin et al., 2005, Mirescu et al., 2006). Indeed it was shown that 
this down-regulating effect of sleep-deprivation occurs during elevated levels of corti-
costerone and was prevented by clamping high levels of corticosterone (Mirescu et al., 
2006). In contrast to effects of prolonged sleep deprivation, just one night sleep depri-
vation significantly increased cell proliferation and the total number of surviving cells in 
the hippocampal dentate gyrus (Grassi Zucconi et al., 2006).  
Neurogenic niche 
The neurogenic niche describes a special microenvironment in the neurogenic regions 
SGZ and SVZ, facilitating and regulating neurogenesis in the adult mammalian brain. In 
the SGZ, neuronal precursor cells lay close to a dense layer of granule cells containing 
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both mature and immature neurons. As mentioned above, astrocyte-like cells function 
as precursor cells of these regions. Apparently another specific population of astro-
cytes acts as regulator cells in the neurogenic niche. It was shown that these cells in-
struct the stem cells to adopt a neuronal fate and promote their proliferation (Song et 
al., 2002). In cell culture systems, this group demonstrated that these effects of astro-
cytes seem to be regionally specified. Astrocytes from the adult HC retain the ability to 
promote neurogenesis, whereas astrocytes of the spinal cord do not. In the regulation 
of adult neurogenesis by astrocytes, a cell-cell contact seems to be crucial, which was 
shown in vitro. Thus, SVZ cells proliferate rapidly on an astrocyte-monolayer in a cul-
ture system free of serum or exogenous growth factors (Lim and Alvarez-Buylla, 1999). 
Molecular signals released by astrocytes seem to be involved too. Transplantation of 
SGZ cells into the neocortex of adult mice promotes neurogenesis in this non-
neurogenic region (Jiao and Chen, 2008). It was demonstrated that a significant pro-
portion of radial glia-like cells (type 1 cells) in the dentate gyrus are coupled by gap 
junctions indicating a possible communication pathway (Kunze et al., 2009). Induction 
of virus-mediated ablation of connexins, key constituents of gap junctions, led to a 
dramatic decrease of proliferation and reduced numbers of radial glia-like cells and 
granule neurons in the adult dentate gyrus of the HC. Furthermore precursor cell activi-
ty seems to be calcium dependent. Excitation sensed via calcium channels on the pro-
liferating precursors increases expression of NeuroD, a positive regulator of neuronal 
differentiation (Deisseroth et al., 2004). As described above, the precursor cells in the 
SVZ lay right next to the ependymal cell layer of the lateral ventricles. By expressing 
the protein Noggin, ependymal cells may promote SVZ neurogenesis. Noggin antago-
nizes the action of bone morphogenetic proteins, an inhibiting factor for adult neuro-
genesis, expressed by SVZ cells (Lim et al., 2000). Another factor derived from the 
ependymal cells is the pigment epithelium-derived factor which promotes self-renewal 
of adult NSCs (Ramirez-Castillejo et al., 2006). Important cellular components of the 
neurogenic niche are blood vessels (Palmer et al., 2000, Palmer, 2002). Endothelial 
cells secrete soluble factors which stimulate self-renewal and enhance neurogenesis of 
NSC in vitro (Shen et al., 2004). As in the regulation of vascularisation, the vascular 
endothelial growth factor (VEGF) also plays an important role in regulating neurogene-
sis (Cao et al., 2004, Jin et al., 2002). It even seems to be the crucial regulating factor 
in exercise-induced neurogenesis in adult hippocampal neurogenesis (Fabel et al., 
2003). Fabel et al. demonstrated that peripheral blockade of the VEGF receptor abol-
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ished running-induced neurogenesis but had no detectable effect on baseline neuro-
genesis in non-running animals.  
Neurotransmitters 
Neurotransmitters are frequently involved in cell-to-cell signaling. Axon terminals end-
ing at the dentate gyrus of HC coming from a variety of brain regions distribute many 
different transmitters. The innervation of the SVZ seems to be less dense than that of 
the SGZ (Kempermann, 2011). Excitatory glutamatergic neurons project from the ento-
rhinal cortex via the perforant pathway to the granule cells of the dentate gyrus. Effects 
by different ionotropic receptors, N-Methyl-D-Aspartat (NMDA), Kainate (KA) and α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, are not ho-
mogenous but intricately balanced so that glutamate elicits a range of different re-
sponses in the same cells (Cameron et al., 1995, Gould et al., 1997, Kempermann, 
2011). In summary, glutamatergic neurotransmission acts pro-neurogenic. In addition, 
SGZ and SVZ are innervated by cholinergic neurons coming from the nucleus basalis 
of Meynert and the septal region. Lesioning cholinergic neurons in the forebrain, relia-
ble achieved with an immunotoxin, caused a reduction in adult neurogenesis in both 
the HC and the OB (Cooper-Kuhn et al., 2004). Hence, the cholinergic system seems 
to have a survival-promoting effect (Kempermann, 2011). The neurotransmitter seroto-
nin plays a key role in brain development (Gaspar et al., 2003). Accordingly, it is plau-
sible to attribute serotonin with the regulation of adult neurogenesis. Serotonergic af-
ferents project from the raphe nuclei in the brain stem to the SGZ. Indeed, seroto-
ninergic input was found to increase adult neurogenesis in the HC and the SVZ. This 
was demonstrated by inhibition of serotonin synthesis or selective lesions of serotonin 
neurons which led to a decrease in the number of newly generated cells in the dentate 
gyrus and in the SVZ (Brezun and Daszuta, 1999). Dopaminergic fibers coming from 
the midbrain also innervate the SVZ (Hoglinger et al., 2014). Höglinger et al. were able 
to demonstrate that type C cells in the SVZ express dopamine receptors (2004). Do-
pamine denervation decreased adult neurogenesis in the OB in vivo, whereas activa-
tion of the dopaminergic receptor D2 led to increased proliferation in vitro. Also exten-
sive noradrenergic projections reach the dentate gyrus from the locus coeruleus (Loy et 
al., 1980). Results of one study indicate that the proliferation, but not the survival or 
differentiation of adult hippocampal granule cell progenitors is affected by noradrenalin 
depletion (Kulkarni et al., 2002). For the development of new neurons in the dentate 
gyrus, GABA plays an important role. It has been demonstrated, that GABAergic inputs 
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to hippocampal progenitor cells promote activity-dependent neuronal differentiation 
(Tozuka et al., 2005). 
3.1.3 Adult neurogenesis in the human brain 
In 1998 the Swedish neurologist Peter Eriksson histologically examined the brains of 
laryngeal cancer patients, who had received an injection of BrdU at lifetime for diagnos-
tic purposes. Beside an enrichment of BrdU in cancer cells, he could also detect this 
proliferation marker in mitotically active neural precursor cells of the HC. This was the 
first evidence suggestive of adult neurogenesis in the human brain (Eriksson et al., 
1998). As further evidence, the detection of BrdU-immunoreactive neurons in the hu-
man OB followed (Curtis et al., 2007). Human neurogenic regions presumably include, 
like in rodents, the SVZ and the OB because the expression of cell cycle-associated 
and cell-type-specific proteins suggestive of neurogenesis in human cells was shown in 
these regions (Sanai et al., 2004, Bedard and Parent, 2004, Liu and Martin, 2003). 
Moreover, cells with stem cell properties could be isolated out of the SVZ and the HC 
(Kukekov et al., 1999, Roy et al., 2000b, Roy et al., 2000a, Hermann et al., 2006a, 
Maisel et al., 2007). However, the existence of the RMS, important for migration of new 
born cells from the SVZ to the OB in rodents, is still much debated in humans (Curtis et 
al., 2007, Sanai et al., 2004, Sanai et al., 2007).  
3.1.4 Functions of adult neurogenesis 
3.1.4.1 Hippocampus 
It proofs to be difficult to assess the precise functional relevance of adult neurogenesis 
in the HC, since the function of the HC in itself is not yet fully understood. A widely ac-
cepted idea is that the HC consolidates declarative memory contents, meaning that it 
processes information for long-term memory storage. It is supposed that the dorsal HC 
takes part in learning and memory, whereas the ventral HC participates in regulating 
affective behaviors (Bannerman et al., 2004). Morris showed that hippocampal lesions 
cause impaired place navigation in rats and demonstrated thereby, that spatial memory 
depends on hippocampal functions (Morris et al., 1982). Today, the Morris water maze 
is a common HC-dependent memory test investigating the spatial memory: Animals are 
placed in a pool of water that is colored opaque and have to find an escape platform 
hidden under the surface (Morris et al., 1982). This is studied repeatedly on successive 
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days. Rodents with unimpaired spatial-memory will find the platform more rapidly after 
each trial.  
Kempermann and Gage (2002) found a significant correlation between the number of 
new neurons generated in the dentate gyrus and parameters describing the acquisition 
of the water maze task. Memory acquisition reflects how fast an animal learns the task. 
Conclusively, adult neurogenesis is involved in specific aspects of hippocampal func-
tion, particularly in the acquisition of new information. One group points out that spatial 
learning modifies neurogenesis by a selective cellular stabilization process (Dupret et 
al., 2007). They were able to demonstrate, that spatial learning promotes survival of 
relatively mature neurons, apoptosis of more immature cells, and finally, proliferation of 
neural precursors. The relevance of apoptosis in this process was shown by blocking 
apoptosis during the late phase of Morris water maze training, which led to impaired 
performance in rats. The conclusion of these observations was that during learning, 
neuronal networks are sculpted by a tightly regulated selection and suppression of dif-
ferent populations of newly born neurons (Dupret et al., 2007). To investigate the func-
tion of hippocampal neurogenesis in learning and memory, different experimental 
methods have been developed to decrease or even ablate SGZ neurogenesis in adult 
animals using drugs or radiation. In general, results of these studies led to the assump-
tion that adult neurogenesis has a functional relevance for hippocampal-dependent 
cognitive performance (Shors et al., 2001, Shors et al., 2002, Snyder et al., 2005). In 
2001, Shors et al. used a toxin killing proliferating cells, the DNA methylating agent 
methylazoxymethanol acetate, to diminish adult neurogenesis in dentate gyrus of rats. 
By performing different HC conditioning experiments they concluded that adult neuro-
genesis in the HC is involved in the formation of trace memories (Kempermann et al., 
2004b, Shors et al., 2001). By using low-dose irradiation to inhibit adult hippocampal 
neurogenesis it has been shown that adult neurogenesis plays an important role in the 
formation and consolidation of long-term spatial memories (Snyder et al., 2005). A re-
cent study confirms the role in long-term spatial memories and furthermore found an 
impairment of object recognition memory (Jessberger et al., 2009). A correlation be-
tween hippocampal neurogenesis and learning was observed in mice with different 
genetic background that influences the levels of cell proliferation, differentiation and 
survival (Zhao et al., 2008, Saxe et al., 2006). The group of Kempermann postulated, 
by analogy with a computer, addition of new neurons does not mean installing a new 
hard ware for more storage, but rather strategic changes in the network architecture 
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lead to an optimization of the performance (Biebl et al., 2000). According to the current 
concept, explicit memory contents have to be processed in the HC before its consolida-
tion and long-term storage in cortical structures. One hippocampal particularity lies in a 
structural bottleneck in the neuronal network, which is exactly the position at which 
adult neurogenesis occurs. The bottleneck lies in the mossy fiber projection of the den-
tate gyrus into the much smaller region CA3. The new neurons contribute to the mossy 
fiber tract and thereby structurally counteract the narrowness of this spot 
(Kempermann, 2002, Kempermann, 2008, Brandt and Storch, 2008).  
In recent years the role of adult neurogenesis in the HC in the context of depression 
has been studied extensively. Empirical and experimental data build a connection be-
tween alterations of cellular plasticity in the HC and the pathophysiology of depression 
(Brandt and Storch, 2008). On the empirical side, several studies demonstrate patients 
with known depression perform significantly worse in HC-dependent memory tests 
(Gould et al., 2007) and the HC has a lower volume than comparable control groups 
(Campbell et al., 2004, Videbech and Ravnkilde, 2004). Furthermore many antidepres-
sants lead to a stimulation of the hippocampal neurogenesis (Malberg et al., 2000, 
Czeh et al., 2001, Santarelli et al., 2003). In addition, the effectiveness of antidepres-
sants is abolished in the absence of adult neurogenesis (Santarelli et al., 2003, Duman 
and Monteggia, 2006, Jiang et al., 2005). As mentioned above, one night sleep depri-
vation significantly increased cell proliferation and the total number of surviving cells in 
the hippocampal dentate gyrus (Grassi Zucconi et al., 2006). This response could be 
partially responsible for the beneficial effect, elicited in depressed patients by one night 
sleep deprivation.  
Taken together, these findings suggest that hippocampal neurogenesis depends on 
functional demands of the HC and some functions of the HC in return depend on neu-
rogenesis.  
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3.1.4.2  Olfactory bulb 
In order to interpret the behavioral experiments investigating the function of adult neu-
rogenesis in the OB, the influence of the newly formed cells at the cellular level has to 
be illustrated. Imayoshi (2008) made an important contribution in understanding the 
function of adult neurogenesis in the OB. Using a genetic method for labeling NSC in 
adult mice, they could show that continuous neurogenesis results in the replacement of 
the majority of granule neurons in the OB. In addition, inhibition of adult neurogenesis 
resulted in a substantial reduction of the granule cell number. Due to these observa-
tions it was postulated, that continuous neurogenesis is required for the maintenance 
and reorganization of the whole interneuron system in the OB. Using a mouse model, 
lacking the neural cell adhesion molecule (NCAM), necessary for the migration of new-
ly formed cells through the RMS, the anatomical and behavioral consequences of failed 
neurogenesis was further analyzed by Gheusi et al. (2000). They found disturbances in 
the discrimination between different odors and were able to correlate low performance 
in odor differentiation to a specific reduction in a newly generated interneuron popula-
tion. In contrast, the detection limits for both odors and short-term olfactory memory 
were unaffected. Therefore they assumed that a critical number of bulbar granule cells 
is crucial for odor discrimination in particular, but not for general olfactory functions. 
Another group assumes that adult neurogenesis in the OB allows the constant adaption 
to new odor information from the environment (Lledo and Saghatelyan, 2005). Olfaction 
is the main sensory input for rodents. Several studies demonstrate that an odor-
enriched environment results on the one hand in an increased neuron survival rate in 
the OB and on the other hand improves odor memory (Petreanu and Alvarez-Buylla, 
2002, Yamaguchi and Mori, 2005, Rochefort et al., 2002). Therefore, the function of 
neurogenesis cannot be separated from its regulation.  
3.1.5 Adult neurogenesis and neurodegenerative diseases 
Interestingly, in different neurological disorders such as stroke, Huntington’s disease 
and Alzheimer’s disease, an increase in precursor cell proliferation and neurogenesis 
in these neurogenic niches have been observed (Curtis et al., 2003, Arvidsson et al., 
2002, Perry et al., 2012). Arvidsson et al. (2002) showed, that stroke, caused by transi-
ent middle cerebral artery occlusion in adult rats, leads to a marked increase of cell 
proliferation in the SVZ. Moreover, they have shown that stroke-induced new neuro-
blasts are probably already formed before the insult, migrate into the severely dam-
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aged area of the striatum, where they express markers of developing and mature, stria-
tal medium-sized spiny neurons. Thus, stroke induces differentiation of new neurons 
into the phenotype of most of the neurons destroyed by the ischemic lesion. These 
findings indicate that ischemic neuronal death transmits signals to the new neurons to 
migrate into the damaged area of the striatum. A flow of new neurons with migratory 
morphologies could be traced back to the SVZ. These neurons sometimes formed ag-
gregates, suggesting that some of them may reach the damaged area using chain mi-
gration, similar to neuronal precursors in the rostral migratory stream. In sharp contrast, 
there is a reduction in precursor cell proliferation in the SVZ of Parkinson’s disease 
(PD) patients and corresponding experimental animal models (Hoglinger et al., 2004, 
Freundlieb et al., 2006). Höglinger et al. have shown that the generation of neuronal 
precursor cells is impaired in Parkinson disease as a consequence of dopaminergic 
denervation. 
3.2 The orexin system 
3.2.1 Orexin peptides and their receptors 
In 1998 two scientific working groups, De Lecea et al. and Sakurai et al., could inde-
pendently identify two similar and previously unknown neuropeptides. De Lecea et al. 
(1998) used directional tag PCR subtraction to identify 38 rat mRNAs selectively ex-
pressed within the hypothalamus. Hereunder they detected an mRNA, which was very 
similar to secretin, a peptide hormone produced in the S cells of the duodenum. Be-
cause of the homology to secretin and the location of its producing cells within the lat-
eral and dorsal hypothalamic area, these hormones were named hypocretin 1 and 2. 
Sakurai et al. (1998) on the other hand detected the same neuropetides by chance, 
while they were searching for some ligands for orphan G-proteins. As they noted that 
the administration of these peptides to rats increased their food intake, they named the 
peptides orexin A and B after the Greek word for hunger (Orexis), and the two orphan 
G-protein receptors orexin receptor 1 and 2. In the literature, hypocretin and orexin are 
still used as synonyms. For better comprehension the term orexin will be used exclu-
sively in the following text. 
The orexins are split products of a common precursor peptide named prepro-orexin 
encoded by one gene located on chromosome 11. Orexin A is a 33-amino acid residue 
peptide with two intrachain disulfide bonds, while orexin B is a linear 28-residue pep-
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tide. Both peptides are amidated at their C terminals. While the C-terminal shows great 
homology between the two peptides, the N-terminal differs largely in the amino acid 
sequence (Sakurai et al., 1998). The corresponding receptors are G-protein coupled 
and are termed orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R). Although the 
receptors are very similar in structure, they exhibit a different affinity for the two neuro-
peptides. Orexin A and B bind equally well to OX2R, however orexin A shows a higher 
affinity to OX1R. OX1R is an activating G-protein. OX2R in contrast shows both, inhibito-
ry and activating effects on its activation. Moreover, the two receptors show a different 
and basically complementary distribution within the brain, suggesting that they have 
distinct physiological functions (Sakurai, 2007, Kroeger and de Lecea, 2009, Peyron et 
al., 1998, de Lecea et al., 1998, Sakurai et al., 1998).  
3.2.2 Neuroanatomy  
The orexin-producing cells are located in the posterior hypothalamus, more precisely in 
its lateral and perifornical areas (Peyron et al., 1998). Up to 3200 of these cells, exclu-
sively producing orexin, were found in mouse brains (Modirrousta et al., 2005). In 
healthy human brains approximately 50,000-90,000 orexin cells are present 
(Thannickal et al., 2000). The axonal projections of orexin neurons are widely distribut-
ed in the brain (Nambu et al., 1999). Orexin nerve terminals were observed throughout 
the hypothalamus, including the arcuate nucleus, the tuberomammillary nucleus and 
paraventricular hypothalamic nucleus. Outside the hypothalamus, orexin fibers were 
detected in the cerebral cortex, medial groups of the thalamus, and in circumventricular 
organs, such as the subfornical organ and the area postrema. Moreover the limbic sys-
tem, more precisely HC, amygdala, and indusium griseum, is innervated by orexin. 
Furthermore fibers project to the brain stem, specifically to the locus coeruleus and the 
raphe nuclei. Less prominent projections were found in the OB (Peyron et al., 1998). 
3.2.3 Physiological and pathophysiological functions 
Regarding the widely spread projections throughout the brain, it can be assumed that 
orexin holds many different functions. The following chapter will illuminate the best 
characterized of the various known physiological and pathophysiological functions of 
orexin, starting with its role in the regulation of hunger and food intake. Thereafter, 
orexin’s effects on the hypothalamus-pituitary-adrenal (HPA) axis, the sympathetic out-
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flow and its role in the reward system will be described. Finally its influence on the reg-
ulation of the sleep-wake cycle and the sleep stages will be shown.  
3.2.3.1 Feeding regulation and food intake 
The lateral hypothalamic area (LHA) was already known as a classical region relevant 
for feeding regulation and energy homeostasis, when orexin neuropeptides were dis-
covered. Several years before this, lesion- and electrical stimulation-studies gave 
ground-breaking information: animals with lesions of the LHA exhibit hypophagia and 
an increased metabolic rate, whereas acute electrical stimulation of the LHA causes 
hyperphagia and chronic stimulation causes even obesity (Danguir and Nicolaidis, 
1980, Bernardis and Bellinger, 1996, Levitt and Teitelbaum, 1975). Since orexin neu-
rons were specifically detected within and around the LHA, its role in feeding regulation 
has been analyzed in several studies. Sakurai et al. (1998), who consequently named 
the neuropeptide after this function, gave the first evidence for the role of orexin in 
feeding regulation. They showed that intracerebroventricular administration of orexin 
into the brain of rats leads to increased food consumption. This effect seems to be due 
to orexin A via the orexin receptor 1 (Haynes et al., 2000, Haynes et al., 2002). The 
admission of NPY-receptor antagonists reduces the effect of orexin A. Accordingly the 
NPY system is probably one of the downstream pathways by which orexin A induces 
feeding behavior (Yamanaka et al., 2000). In support to this assumption the arcuate 
nucleus (ARC), containing the NPY neurons, was shown to be densely innervated by 
fibers of orexin (Date et al., 1999, Peyron et al., 1998). Beside the effect via the NPY 
pathway, feeding regulation of orexin also includes the inhibition of glucoreceptive pro-
opiomelanocorticotropin (POMC) expressing neurons. POMC neurons are located in 
the ARC as well. However their activation suppresses food intake. An opposing player 
of orexin is leptin, which plays a fundamental role in maintaining body weight homeo-
stasis by reducing appetite (Zhang et al., 1994). The major mechanism by which leptin 
suppresses feeding is the inhibition of NPY-Neurons and excitation of POMC-Neurons 
(Hakansson and Meister, 1998, Elias et al., 1999). As leptin can only partly inhibit orex-
in-induced increase of food intake, orexin-induced feeding seems to involve both leptin-
sensitive and -insensitive pathways (Zhu et al., 2002). This may suggest that one rea-
son for leptin resistance in obese humans might be the activation of this leptin-
insensitive pathway by orexin (Nishino and Sakurai, 2006). Yamanaka et al. (2003) 
have shown that the activity of isolated orexin neurons is inhibited by glucose and lep-
tin and stimulated by ghrelin. Thereby, they function as indicators of the energy bal-
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ance. Mice, in which orexin neurons were ablated, failed to respond to fasting with in-
creased wakefulness and activity. This observation allows the assumption that orexin 
regulates arousal according to energy balance. Regarding body weight homeostasis, 
orexin has opposite impacts on feeding and metabolic rates. Hence, orexin increases 
food intake (Sakurai et al., 1998) and at the same time metabolic rate (Lubkin and 
Stricker-Krongrad, 1998). 
3.2.3.2 Autonomic nervous system, neuroendocrine system and reward 
system 
The emotional experience of fear leads to increased arousal and vigilance levels, ac-
companied by increased HPA axis activity and sympathetic outflow in animals. Orexin 
neurons are thought to be involved in the regulation of these responses to stressful 
situations (Mieda and Sakurai, 2009). The perifornical area, where orexin neurons are 
located, is known to function as the centre of defense responses, also known as the 
“fight or flight” response, which is characterized by an increase of arterial blood pres-
sure, heart rate, and respiratory frequency (Jansen et al., 1995). In tracing studies the 
existence of afferents from several regions of the limbic system, responsible for the 
emotional experience of fear and other emotional states, to orexin neurons was shown. 
This included the amygdala, the infralimbic cortex, the nucleus accumbens, the lateral 
septum, and the brainstem (Sakurai et al., 2005, Yoshida et al., 2006).  
A high density of orexin fibers and orexin-2-receptors (OX2R) has been identified in 
neurons of the hypothalamic paraventricular nucleus (PVN) (Sakurai et al., 1998, 
Trivedi et al., 1998, Date et al., 1999), which is thought to be involved in control of the 
autonomic nervous system, cardiovascular function and neuroendocrine system. 
Several findings underline the neuroendocrine influence of orexin in the sense of an 
activation of the HPA axis. The HPA axis consists of corticotropin-releasing hormone 
(CRH) and arginin vasopressin neurons in the paraventricular nucleus (PVN) of the 
hypothalamus which regulates the secretion of ACTH in the anterior pituitary gland. 
ACTH in turn affects the adrenal cortical glucocorticoid secretion. Jaszberenyi et al. 
administered orexin intracerebroventricularly to adult male rats and demonstrated by 
measuring consecutively increased levels of plasma corticosterone an orexin-induced 
activation of the HPA axis. Pretreatment with the CRH antagonist alpha-helical CRH9-
41 completely prevented the action of orexins, accordingly orexin effects on the HPA 
system are mediated by CRH (Jaszberenyi et al., 2000). These results suggesting 
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orexin participates in the stress response through effects on CRH in the PVN. The in-
fluence of orexin on the autonomic nervous system was also shown by intracerebro-
ventricular administration. After injection increased mean arterial pressure, heart rate 
and renal sympathetic nerve activity in conscious rats was observed (Shirasaka et al., 
1999). 
Moreover, orexin seems to influence the reward system and drug addiction (Mieda and 
Sakurai, 2009). Dopaminergic projections from the ventral tegmental area to the nucle-
us accumbens are classically known as the “reward pathway”. Orexin neurons are in-
terconnected with dopamine neurons in the ventral tegmental area and in the nucleus 
accumbens (Yoshida et al., 2006, Peyron et al., 1998, Fadel and Deutch, 2002). This 
pathway is also stimulated by drug abuse. Interestingly, patients with narcolepsy be-
come rarely drug addicted, when they were treated with amphetamine-like stimulants 
against daytime-sleepiness (Guilleminault et al., 1974). 
3.2.3.3 Influence on sleep and wakefulness and the sleep stages 
The finding that orexin deficiency results in symptoms and pathophysiology of a dis-
ease called narcolepsy (Peyron et al., 2000, Chemelli et al., 1999, Lin et al., 1999, 
Thannickal et al., 2000) offered the possibility for a better understanding of its role in 
the regulation of sleep and wakefulness. Narcolepsy is characterized by the inability to 
maintain vigilance states, pathological intrusion of rapid eye movement (REM) sleep 
and/or non-REM (NREM) sleep into wakefulness and frequent transitions between the 
states of sleep and wakefulness. These symptoms indicate that orexin plays an im-
portant role in maintenance and stabilization of sleep and wakefulness. The clinical 
manifestation of narcolepsy will be further explained in detail in a separate chapter. 
The brain circuitry that regulates our daily cycles of sleep and wakefulness includes 
various brain regions and neurotransmitters. Wakefulness and arousal depend on a 
network of cell groups, which is located in the brainstem and activates the thalamus 
and the cerebral cortex. They are functionally combined into the ascending reticular 
arousal system (ARAS) (Saper et al., 2001). The ARAS contains two pathways, one 
that innervates the thalamus and a second that extends into the posterior hypothala-
mus and forebrain (Fig.3).  
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Fig. 3 A schematic drawing showing key components of the ascending arousal system (ARAS). 
Illustration taken from Saper et al. (2005). 
The cholinergic pedunculopontine (PPT) and laterodorsal tegmental nuclei (LDT) pro-
ject from the caudal midbrain and rostral pons to the thalamus and are thought to be 
essential in activating thalamocortical transmission (Hallanger et al., 1987). With differ-
ent behavioral states PPT and LDT neurons change their activity. During wakefulness 
and REM-sleep many PPT and LDT neurons fire rapidly, whereas at sleep only few 
PPT and LDT neurons are active (Jasper and Tessier, 1971). The second branch of 
the ARAS projects into the lateral hypothalamus, basal forebrain, and the cerebral cor-
tex (Saper, 1985, Jones, 2003). It comprises a number of monoaminergic cell popula-
tions, including noradrenergic neurons of the locus coeruleus, serotoninergic dorsal 
and median raphe nuclei, dopaminergic neurons of the ventral periaqueductal grey 
matter and the histaminergic tuberomammillary nucleus. They show the highest activity 
during wakefulness, slow down during NREM sleep, and are nearly inactive during 
REM sleep (Steininger et al., 1999, Aston-Jones and Bloom, 1981, Fuller et al., 2006).  
A key switch in the hypothalamus shuts off this arousal system during sleep. This is 
done by neurons located in the ventrolateral preoptic nucleus (VLPO), which inhibits 
the ARAS by using the neurotransmitters GABA and galanin (Fig.4). 
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Fig. 4 A schematic drawing showing primary projections of the VLPO to the main components 
of the ascending arousal system. Illustration taken from Saper et al. (2005). 
 At the state of wakefulness the monoaminergic neurons of the ARAS inhibit the VLPO. 
This neuronal circuit is called flip-flop switch, a term originally used by engineers. The 
flip-flop switch sets up a self-reinforcing loop, where activity in one of the competing 
sides shuts down inhibitory inputs from the other side, and therefore disinhibits its own 
action. In this system the transitional state is very rare, because when either side be-
gins to overcome the other, the switch ‘flips’ into the alternative state (Saper et al., 
2001, Saper et al., 2005). 
The orexin neurons stabilize the switch (Fig 5). Through excitatory projection to neu-
rons in the locus coeruleus, tuberomammillary nucleus and ventral tegmental area 
(Hagan et al., 1999, Brown et al., 2001, Eriksson et al., 2001), orexin neurons reinforce 
the arousal system during wakefulness and are inhibited by the VLPO cells during 
sleep (Yoshida et al., 2006). Since VLPO neurons do not express orexin receptors 
(Marcus et al., 2001), there seems to be no direct but only indirect influence via the 
activation of the ARAS. By increasing the activity of the arousal regions and thereby 
indirectly inhibiting the sleep-promoting VLPO neurons, orexin gives the state of wake-
fulness more consistency, coordination and prevents inappropriate transitions into 
sleep. In narcolepsy the activating influence of orexin is reduced and the flip-flop circuit 
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becomes unstable and more vulnerable to small changes in homeostatic sleep drive, 
which refers to the desire to sleep that gradually increases with prolonged wakefulness 
(Mochizuki et al., 2004, Scammell, 2003, Nishino and Sakurai, 2006). Narcoleptic pa-
tients do not sleep more than normal individuals, but easily doze off during the day and 
wake up more frequently during night (Saper et al., 2005, Sakurai, 2007). 
 
Fig. 5 A schematic diagram of the flip-flop switch model. Illustration taken from Saper et al. 
(2005). 
This model could also explain the rapid transitions into REM sleep or fragments of 
REM sleep, which are seen in narcoleptics. As described above, orexin neurons send 
many fibers to the locus coeruleus and to the raphe nuclei. The locus coeruleus, tuber-
omammillary nucleus and raphe nuclei contain orexin receptors (Marcus et al., 2001) 
and all three groups inhibit REM sleep (Strecker et al., 2000). Bourgin at al. proposed, 
that orexin receptor 1 in the locus coeruleus is a key target for REM sleep regulation. 
Accordingly local administration of orexin A, but not of orexin B, in the locus coeruleus 
suppressed REM sleep in a dose-dependent manner and increased wakefulness at the 
expense of deep, slow-wave sleep (Bourgin et al., 2000). In addition intracerebroven-
tricular administration of orexin A in rats, prepared for electroencephalography and 
electromyography recording, showed an increased latency in the onset of the first REM 
period (Smith et al., 2003). In the absence of an excitatory orexin input, the weakened 
arousal influence and increased activity of the extended VLPO would allow earlier and 
more frequent transitions to the REM state (Saper et al., 2001). 
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3.2.4 Narcolepsy 
Narcolepsy was first described in 1880 by Gélineau. In the guidelines of the Deutsche 
Gesellschaft für Neurologie (DGN), narcolepsy is defined as a sleep-wake disorder with 
REM and non-REM sleep associated symptoms existing longer than 6 months, such as 
daytime sleepiness, cataplexy, fractionated sleep at night and automatic behavior. Re-
duced sleep latencies and early onset REM sleep can be observed in polysomnogra-
phy (DGN, 2008). Excessive daytime sleepiness (EDS), a feeling of severe sleep-
deprivation or chronic tiredness, the cardinal symptom of narcolepsy manifests in dif-
ferent ways (Nishino, 2007). Patients generally experience a permanent sleepiness, 
which is only shortly relieved by quick naps (15-30 min). In addition, they do suffer from 
sleep attacks (few seconds), which occur in very unusual situations such as in the mid-
dle of a meal and sometimes are followed by automatic behaviors. During such periods 
patients go on with their activity in a semi-conscious manner and might write or say 
incoherent things. Within five years after appearance of EDS, the pathognomonic 
symptom cataplexy occurs in two third of the cases. This phenomenon is defined as a 
sudden episode of muscle weakness triggered by emotional factors such as laughter. 
In the beginning the patients are awake but may have blurred vision or ptosis for a few 
seconds. It is a variable clinical symptom often occurring only mild with simple buckling 
of the knees, head dropping, facial muscle flickering, sagging of the jaw or weakness in 
the arms (Gelb et al., 1994). Between 2 and 7 years after the onset of EDS, 20-50 % of 
the patients develop sleep paralysis. This symptom appears in a brief inability to per-
form voluntary movements at the onset of sleep, upon wakening during the night or in 
the morning, which can be associated with frightening hallucinations. However, this 
phenomenon also occurs among 5-40 % of the general population. Hypnagogic and 
hypnopompic hallucinations are abnormal visual or auditory perceptions that occur 
while falling asleep (hypnagogic) or upon waking up (hypnopompic) and occur during 
REM-sleep (Nishino, 2007). Accompanying phenomena are obesity, memory and con-
centration problems, doze off related accidents, depression, erectile dysfunction, per-
sonality changes  and  headache (Sturzenegger and Bassetti, 2004). Narcolepsy often 
coexists with other sleep disorders, like obstructive sleep apnea syndrome, periodic 
limb movements in sleep, REM sleep behavior disorder, and nocturnal eating disorder 
(Sansa et al., 2010, Knudsen et al., 2010, Spaggiari et al., 1994). 
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The prevalence of narcolepsy ranges between 26-50/100000 (Hublin et al., 1994, 
Ohayon et al., 1996, Longstreth et al., 2007). The disease manifests mostly in the se-
cond decade before the age of 21 (Guilleminault and Pelayo, 1998). Mutations in orex-
in-related genes are rare in humans. Only a single case with early-onset narcolepsy (6 
months of age) was found to be associated with a single-point mutation in the prepro-
orexin gene (Peyron et al., 2000). Despite the lack of genetic abnormalities in the orex-
in system, it was found that human narcoleptics have an 85-95 % reduction in the 
number of orexin neurons (Thannickal et al., 2000). Moreover the presence of gliosis in 
the orexin cell region was shown, which is consistent with a degenerative process be-
ing the cause of the orexin cell loss in narcolepsy. However the pathogenesis seems to 
be multifactorial with decreased orexin containing neurons in the dorsolateral hypothal-
amus, as well as disturbances in the cholinergic and noradrenergic (NA) system (Lin et 
al., 1999). 98 % of Caucasian narcoleptic patients have the HLA DRB1 * 1501, DQB1 * 
0602-type, making it the disease with the highest HLA association. This HLA type has 
a high sensitivity of 95 % but a low specificity, since it is detectable in 25-35 % of the 
general population (Mignot et al., 1994a, Mignot et al., 1999, Poirier et al., 1986). 
Against this background, an autoimmune cause for the destruction of orexin-producing 
neurons was postulated. However the failed search for neuron-specific and organ-
specific auto-antibodies in the serum could not support the hypothesis (Black et al., 
2002). Most cases of human narcolepsy are sporadic, a familial clustering accounts for 
only 10 % of the patients and only 25–31 % of monozygotic twins are reported to be 
concordant for disease (Mignot, 1998). Therefore a gene-environment interaction is 
highly likely (Longstreth et al., 2007, Ton et al., 2010).  
One etiologic model for narcolepsy suggests that some environmental toxin selectively 
and irreversibly destroys orexin-producing cells in individuals with human leukocyte 
antigen (HLA) DQB1*0602 (Longstreth et al., 2007, Mignot, 1998). A highly sensitive 
and specific finding for narcolepsy is the reduction of orexin in the cerebrospinal fluid 
(CSF) below the detection limit. This is found in about 85 % of narcolepsy-cataplexy 
cases (Bassetti et al., 2003, Ripley et al., 2001, Nishino et al., 2000). In one study ana-
lyzing CSF orexin levels for the diagnosis of narcolepsy, most subjects with low levels 
were HLA-DQB1*0602-positive narcolepsy-cataplexy patients. But only a few HLA-
DQB1*0602-positive subjects without cataplexy had low levels. Hence, cataplexy corre-
lates highly to orexin deficiency, in contrast to other REM sleep-related phenomena in 
narcolepsy (Mignot et al., 2002).  Occurrences of cataplexy are rare in acute sympto-
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matic cases of EDS associated with a significant orexin deficiency, therefore it appears 
that a chronic and selective deficit of orexin neurotransmission may be required for the 
occurrence of cataplexy (Nishino, 2007). In 5 – 10 % of the narcolepsy cases, especial-
ly in hereditary/familial forms of the disease, the orexin values can lie within the normal 
range (Khatami et al., 2004).  
3.2.4.1 Treatment 
The treatment of narcolepsy is currently merely symptomatic and mostly requires a 
long-term drug therapy. Daytime sleepiness is treated in general with stimulating drugs. 
Previously used methylphenidate and amphetamine were replaced by modafinil as the 
first-line treatment for EDS and sleep attacks (Billiard, 2008). Modafinil is effective in 
70-80 % of patients (Billiard et al., 2006). Compared to amphetamine, modafinil has an 
additional phenyl and an amid instead of an amine group, which suggests a distinct 
mechanism of action. However the mode of action is still unclear, even if a dopamine 
reuptake inhibition is likely to be involved (Mignot et al., 1994b, Nishino et al., 1998, 
Wisor et al., 2001). Another option is sodium oxybate, the sodium salt of gamma-
hydroxybutyrate (GBH) which corresponds to a natural metabolite of the neurotransmit-
ter GABA. Sodium oxybate has reductive effects on EDS, sleep attacks, cataplectic 
attacks and night time awakenings  (US_Xyrem_Multicenter_Study_Group, 2003). The 
combination of modafinil and sodium oxibate shows an additive effect in treating EDS 
(Black and Houghton, 2006). In case patients become therapy-refractory to the first-line 
treatment against daytime sleepiness, alternative therapies are ephedrine, dextroam-
phetamine and MAO inhibitors. The treatment can be supported by non-
pharmacological behavior-modifying measures, such as improving coping strategies, 
sleep hygiene and customized day-sleep-episodes. Cataplexy, sleep paralysis and 
hypnagogic hallucinations are also treated with sodium oxybate or new antidepressants 
specially venlafaxin or atomoxetine (DGN, 2008, Billiard, 2008). If these treatments are 
inefficient, tricyclic antidepressants or SSRIs can be used. Today the common assump-
tion is that human narcolepsy is caused by orexin deficiency (Thannickal et al., 2000, 
Peyron et al., 2000). Consequently the natural treatment seems to be the replacement 
of orexin. However, research is still at the beginning. One group found normalization of 
sleep/wake patterns and behavioral arrest episodes (equivalent to cataplexy and REM 
sleep onset) in orexin-deficient mouse knockout models, supplemented by central ad-
ministration of orexin (Mieda et al., 2004). Hence they could demonstrate that tempo-
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rally regulated and spatially targeted secretion of orexin is not necessary to prevent 
narcoleptic symptoms. This encouraged research in orexin replacement therapies. 
3.2.5 Animal models of narcolepsy 
In 1973, non-human narcolepsy was first described in a cat and a dog (Knecht et al., 
1973). At Stanford University, a colony of narcoleptic dogs was established in 1976 to 
study the pathophysiology of the disease (Cederberg et al., 1998). After the canine 
genomic bacterial artificial chromosome (BAC) library was built from a Doberman pin-
scher (Li et al., 1999), the positional cloning approach in the canine narcolepsy model 
led to the identification of mutations in the OX2R gene (Lin et al., 1999). Hence, animal 
models gave the first indications that the orexin system seems to be involved in narco-
lepsy. As the two orexin peptides and their two receptors OX1R and OX2R were dis-
covered, the possibility was given to create different types of knockout models in mice. 
Chemelli et al. developed an orexin knockout mouse, induced by targeted disruption of 
the prepro-orexin gene, which results in a phenotype strikingly similar to human narco-
lepsy patients. Hence these mice show symptoms like EDS, cataplexy and other REM 
sleep-related phenomena (Chemelli et al., 1999). OX1R knockout mice seem to have 
no cataplectic attacks and only moderate sleep fragmentation (Willie et al., 2003). 
Orexin double receptor knockout mice have the same phenotype as prepro-orexin 
knockout mice (Chen et al., 2009). The use of constitutive knockout animal models is 
potentially confounded by the compensation of the orexin system during the embryonic 
brain development. A different opportunity exhibits chemical lesion, where orexin-B 
conjugated to the ribosome-inactivating toxic protein saporin is injected into the lateral 
hypothalamus. Consequently this method targets only orexin receptor-bearing neurons. 
Because orexin neurons and non-orexinergic neurons in the lateral hypothalamus ex-
press orexin receptors this method destroys both orexin and non-orexin cells. Treated 
rats showed narcoleptic symptoms like increased slow-wave sleep, REM sleep, and 
sleep-onset REM sleep periods (Gerashchenko et al., 2001). The establishment of an-
tisense or RNA interference (RNAi) technology facilitates a transient inhibition of the 
gene expression of either orexin or its receptors. Animals treated either with the OxR2 
antisense (Thakkar et al., 1999) or with short interfering RNAs (siRNA) targeting the 
prepo-orexin mRNA (Chen et al., 2006) showed an increase in total REM sleep and 
infrequent cataplectic attacks. Advantages of this model comprise its high selectivity, 
reversibility and fast onset. A method which can be used in all species is the use of 
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antagonists against both orexin receptors. Somnolence without cataplexy and a de-
crease of alertness was observed in rats, dogs and humans when the orexin receptor 
antagonists were given during the active phase of their circadian cycle (Brisbare-Roch 
et al., 2007). In rats, increases in electrophysiological markers of non-REM and REM 
sleep were shown additionally. 
As mentioned above mutations in the prepro-orexin or orexin receptor genes seem to 
be unlikely the cause for human narcolepsy. Post-mortem studies indicate a neuro-
degenerative pathogenesis with a global loss of orexin neurons in human narcoleptics 
(Thannickal et al., 2000, Peyron et al., 2000). Thus, Hara et al. (2001) developed a 
mouse model called orexin/ataxin-3 mouse, which mimics the postulated pathophysiol-
ogy of human narcolepsy very closely. They constructed a transgenic model in which 
orexin-containing neurons are ablated by orexinergic-specific expression of a truncated 
cytotoxic gene product. Therefore, they used a fragment of the 5’-upstream region of 
the prepo-orexin gene as a promoter, which was ligated to the N-terminally truncated 
cDNA for human ataxin-3, an expanded polyglutamine stretch known from the Macha-
do-Joseph disease. The expression of this transgene induces apoptosis and results in 
postnatal chronic progressive loss of orexin-containing neurons exclusively. The group 
observed a 99 % loss of orexin cells after 12 weeks of age and could hardly detect any 
orexin cell in the lateral hypothalamic region after 15 weeks (Hara et al., 2001). It could 
be assumed that the phenotype of this mouse model differs from the others, because 
of the global cell loss. Orexin neurons produce also galanin, angiotensin and the en-
dogenous opiate dynorphin (Chou et al., 2001), which may act synergistically with orex-
in to increase the activity of wake-promoting brain regions and influences feeding be-
havior (Walker et al., 1980). Furthermore orexin neurons contain the neuronal activity-
regulated pentraxin (NARP) (Reti et al., 2002) which may contribute to the symptoms of 
human narcolepsy. Interestingly the difference between the actual narcoleptic pheno-
type of prepo-orexin knockout and orexin/ataxin-3 mice does not seem to be intense. 
Differences exist in the temporal appearance of abnormal behavior. Orexin/ataxin-3 
mice become symptomatic after 6 weeks, whereas some of prepro-orexin mice already 
show symptoms at an age of less than 3 weeks. Usually narcolepsy patients show 
symptoms not until adolescence, thus postnatal loss of orexin neurons in the orex-
in/ataxin-3 model is more comparable to the typical human narcolepsy case. Concern-
ing behavioral arrests, duration of episode and sleep state patterns no significant dif-
ferences between prepo-orexin knockout and orexin/ataxin-3 mice could be observed. 
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However the duration of awakening state during the light phase, which equates sleep 
disruption in human narcolepsy at night, was significantly shorter in over 12 week old 
orexin/ataxin-3 mouse than in compared littermates. This difference could not be ob-
served in prepro-orexin knockout mice in comparison to their littermates. In orex-
in/ataxin-3 mice, a metabolic abnormality characterized by reduced food consumption 
combined with decreased motor activity and lower basal metabolic rate results in late 
onset obesity, a symptom also noticed in human narcoleptic patients. In contrast pre-
pro-orexin knockout mice display rather normal weight than obesity although they are 
also hypophagic. Reason for these fine metabolic differences might be the absence of 
orexin-cell-produced neuropeptides like dynorphin (Walker et al., 1980). Moreover the 
fact that postnatal orexin/ataxin-3 mice still produce orexin and are exposed to its mod-
ulatory effects, in contrast to prepo-orexin knockout mice, which are not able to pro-
duce any orexin at any time, could cause a crucial difference. However the fundamen-
tal similar symptoms of these two mouse models underline once more the important 
role of orexin in the regulation of sleep and wakefulness and eating behavior (Hara et 
al., 2001). 
3.3 Orexinergic innervation of the neurogenic brain regions  
A direct, topographically organized innervation of adult NSC and proliferating progeni-
tor cells by orexin has been demonstrated in the SVZ, the SGZ, the RMS and the OB 
by our group (unpublished data). For localization of NSC and progenitor cells nestin-
GFP transgenic mice were used. These are genetically modified mice in which the ex-
pression of nestin and the green fluorescent protein (GFP) were coupled together 
(Mignone et al., 2004). Nestin is an intermediate filament protein that is expressed in 
stem cells of the CNS but not in mature CNS cells (Reynolds and Weiss, 1992). DAPI 
(4',6-diamidino-2-phenylindole) is a fluorescent stain that binds strongly to A-T rich re-
gions in DNA (Kapuscinski, 1995) and thus marks all DNA containing nuclei. By immu-
nofluorescence labelling for orexin A and the OX2R the co-localization of orexin neu-
rons and nestin-GFP labeled adult NSC or proliferating progenitor cells could be shown 
using a confocal laser scanning microscope. 
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Fig. 6: Orexinergic innervation of adult NSC in the SVZ. The picture shows the contact of 
orexinergic dentrites with new built cells in the SVZ. Red: Orexin A; Green: adult NSC. scale 
bar: 10 µm (Image kindly provided by O. Arias-Carrion).  
 
Fig. 7: Orexinergic innervation of new built cells in the OB. Left panel: Overview shows the 
colocalization of Orexin dentrites and new built cells in the periglomerular zone of the OB. Right 
panel: Shows the contact of orexinergic dentrites with new built cells in details. Red: Orexin A; 
Green: new built cells. scale bars: 100 µm (a); 10 µm (b) (Image kindly provided by O. Arias-
Carrion).  
  OB  Periglomerular zone 
SVZ 
a) b) 
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Fig. 8: Orexinergic innervation of new built cells in the RMS. The picture shows the contact 
of orexinergic dentrites with new built cells in the RMS. Red: Orexin A; Green: new built cells. 
scale bar: 10 µm (Image kindly provided by O. Arias-Carrion). 
 
Fig. 9: Orexinergic innervation of adult NSC in the SGZ. The picture shows the contact of 
orexinergic dentrites with new built cells in the SGZ of the HC. Red: Orexin A; Green: new built 
cells. scale bar: 10 µm (Image kindly provided by O. Arias-Carrion). 
 
RMS 
SGZ 
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Fig. 10: Occurrence of OX2R in the HC. Red: OX2R; Blue: Cellular nuclei in the HC. scale bar: 
100 µm (Image kindly provided by O. Arias-Carrion). 
 
3.4 Aim of the study 
In preliminary investigations of our working group, a high density of orexin afferents 
was found in the SVZ, RMS, OB, and SGZ (see introduction 3.3.). This suggests that 
orexin may contribute to regulation of the niches of adult neurogenesis.  
The aim of this study was to evaluate the influence of the orexin system on adult neu-
rogenesis. In this particular study the genetic ablation in the orexin-ataxin mouse was 
investigated.  
The central hypothesis was that orexin, acting at the orexin receptors, suppress the 
proliferation of the adult NSC. If confirmed, in vivo modulation of the orexinergic neuro-
transmission might therefore offer novel options for the stimulation of adult neurogene-
sis with a therapeutic perspective for human patients with neurodegenerative disorders. 
HC 
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4 MATERIAL 
4.1 Equipment 
Material Source 
Tissue freezing medium 
Leica Instruments GmbH – Nussloch, 
Germany 
Glass carrier slide, 25*75*1.0 mm 
Menzel-Gläser GmbH - Braunschweig, 
Germany 
Cover slips, 24*50 mm 
Menzel-Gläser GmbH - Braunschweig, 
Germany 
Microtome-blades, type S35 Feather - Köln, Germany 
Pipettes,10-100 ul/ 100-1000 ul/ 1000 ul Eppendorf AG - Hamburg, Germany 
Pipette tips Eppendorf AG - Hamburg, Germany 
Stereotaxie atlas for mice 
The Mouse Brain in Stereotaxic Coordi-
nates, 2nd edition; Paxinos & Franklin, 
2001 
Terralin-Liquid (disinfectant) Schülke & Mayr - Norderstedt, Germany 
Dry ice 
Pharmacy, Philipps-Universität Marburg, 
Germany 
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4.2 Chemicals 
5-Bromo-2´-Deoxyuridin (BrdU) Vector Laboratories, Burlingame, CA, USA 
Normal Goat Serum (NGS) Sigma, St. Louis, MO, USA 
Normal Horse Serum (NHS) Sigma, St. Louis, MO, USA 
 
4.3 Antibodies 
Name Factory no.: Dilution Company 
Primary antibodies 
Rat anti-BrdU OBT0030 1:500 AbD Serotec, Oxford, UK 
Rabbit anti-TH (thy-
rosine hydroxylase)  
AB152 1:1000 Millipore Billerica, MA, USA 
Mouse anti-NeuN 
(neuronal nuclear 
antigen) 
MAB377B 1:1000 Millipore Billerica, MA, USA 
Secondary antibodies  
Donkey anti-rat 
biotinylated 
712-065-150 1:500 
Jackson ImmunoResearch La-
boratories, Inc. West Grove, PA,  
USA 
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Alexa Fluor 488-
conjugated goat 
anti-rat IgG 
A11006 1:1000 
Invitrogen Carlsbad, Kalifornien, 
USA 
Cy3-conjugated 
goat anti-mouse 
IgG 
115-166-062 1:500 
Jackson ImmunoResearch La-
boratories, Inc. West Grove, PA, 
USA 
Cy5-conjugated 
donkey anti-rabbit 
IgG  
711-175-152 1:500 
Jackson ImmunoResearch La-
boratories, Inc. West Grove, PA,  
USA 
 
4.4 Solutions 
Antifreeze (1 l):  NaH2PO4  1.57 g 
             Na2HPO4    5.18 g 
 H2Odest. 400 ml 
 ethylenglycol  300 ml 
  glycerin   300 ml 
 
Borat buffer (450 ml): boric acid  3.09 g 
 H2Odest.  450 ml 
 adjust to pH 8,5 with 5 N NaOH  
 
DAB 3,3'-Diaminobenzidine (20 ml): Tris  20 ml 
 DAB  10 mg 
 H2O2  2 µl 
 
Gelatine-solution (700 ml): gelatine  3.5 g 
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 Chromium potassium sulfate 0.35 g 
 H2Odest.  700 ml 
 
PB phosphate buffer (10 l): H2Odest.  10 l 
 Na2HPO4*2H2O  230 g 
 NaH2PO4*H2O  52.44 g 
 
PBS phosphate buffered saline (1 l):  0.2 M PB 50ml  
 H2Odest. 950 ml  
  NaCl 9 g 
 
PFA Paraformaldehyde 4% (200 ml): H2Odest. (heat up to 60 °C) 50 ml  
 PFA (add while stirring) 4 g  
 NaOH 10 N  (=> filtrate) 100 µl  
 0.2 M PB  50 ml 
 
Saccharose-solution 30% (400 ml): saccharose  150 g 
 0.1 M PB  400 ml 
 
TBS Tris-buffered saline (2 l): Tris 1 M  500 ml 
 NaCl  17.6 g 
 KCl  0.4 g 
 H2Odest.  2000 ml 
 
Tris HCl-buffer (1 l): Tris  121.1 g 
 H2Odest  1000 ml 
 adjust to pH 7.5 with HCl  
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4.5 Experimental animals 
Adult male and female littermates with (orexin/ataxin-3 mice, n = 16) and without 
(wildtype (WT), n = 16) the orexin/ataxin-3 transgene (Hara et al., 2001) were obtained 
from a congenic line and matched for age and body weight. All used mice were aged 
between 96 and 127 days and weighed between 20 and 35g at the start of treatment. 
Mice were kept under standard conditions (room temperature 23 °C ± 1 °C, humidity 55 
± 5 %, 12-hour light-dark cycle, lights on 6:30 p.m.). 1-5 mice were kept in one cage. 
The animals had standard food (Altromin) and water to drink at free disposal. All exper-
imental procedures involving animals were approved by the Regierungspräsidium 
Gießen and were carried out in accordance with NIH guidelines. 
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5 METHODS 
5.1 Experimental design 
For the evaluation of stem cell proliferation in the SVZ and SGZ and migration in the 
RMS, mice (orexin/ataxin-3 mice n=8; WT n=8) received a single intraperitoneal injec-
tion of 100 mg BrdU/kg body weight 2 hour prior to sacrifice. For the analysis of surviv-
al and differentiation of newly build cells, BrdU was administered intraperitoneally for 5 
consecutive days (one per day) to each mouse (orexin/ataxin-3 mice n=8; WT n=8). 
The last injection was made 30 days before the mice were sacrificed (Fig. 11). Adult 
neurogenesis in the OB, RMS, SVZ and HC was studied by immunohistology as shown 
in table 1.  
 
 Fig. 11: Experimental design 
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Staining Purpose of the staining 
Regions in 
group no.1 
Regions in group 
no.2 
Cresyl violet  overview, cut-ting control all brain regions all brain regions 
BrdU 
quantification of 
proliferation and 
survival  
HC, SVZ and 
RMS HC, OB 
Triple staining 
(BrdU/NeuN/TH) 
differentiation of 
newly built cells 
into neurons/ 
dopaminergic 
neurons 
 HC, OB  
Table 1: Overview of stainings used in this study 
5.2 Bromodeoxyuridine treatment 
BrdU as a synthetic analogue of thymidine, is incorporated in the cellular DNA of prolif-
erating cells in the S phase of mitosis and can be subsequently detected by immuno-
histochemistry. For detection of adult neurogenesis, BrdU labeling is considered as the 
gold standard (Vega and Peterson, 2005). BrdU (Vector Laboratories, Burlingame) was 
dissolved in 0.9 % NaCl and filtered sterile. The mice received single intraperitoneal 
doses of 100 mg BrdU/kg body weight at a concentration of 10 mg/ml. 
5.3 Perfusion  
The purpose of the transcardial perfusion is to drain the blood out of the brain and fix 
the tissue with paraformaldehyde (PFA) to optimize preservation of cellular structures 
and antigens. For this procedure, a Masterflex pump controller (Masterflex, Gelsenkir-
chen, Deutschland), two perfusion fluids (phosphate-buffered saline (PBS, 0.1 M, pH 
7.3), 4 % PFA in PBS), a scalpel, scissors, a cannula, and two large self-holding for-
ceps were prepared. 
After intraperitoneal injection of a lethal dose (40 mg) of pentobarbital, absence of the 
interdigital pain reflex was verified before continuing. The animals were placed on a 
polystyrene board and the body was pinned out using all four extremities. The thorax 
was opened by a median sternotomy. The access to the thoracic cavity was made by 
an incision in the diaphragm. The pericard was cautiously opened with scissors, an 
insert was made carefully into the left heart ventricle and the cannula was placed into it. 
Right after the pump system was turned on, a small incision in the right auricle was 
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done in order to drain the venous blood. The mice were perfused first with 0.1 M PBS 
followed by ice cold 4 % PFA. To ensure blood was fully drained from the brain, each 
solution was applied for the duration of 10 min with a speed of 15ml/min. Therefore, 
150 ml per solution and 300ml fluid were used per brain which equates 4-5 times of the 
blood volume of a mouse. 
5.4 Tissue preparation 
After decapitation with a large, sharp pair of scissors, the brain was removed carefully. 
First the two flaps of skin and muscle were pulled back so that the skull underneath 
was exposed. Using a small, sharp pair of scissors, the skull bone was cut along the 
sagittal sutura before the skull was broken up. For post-fixation, brains were placed in a 
4 % PFA solution and stored at 4°C until they sank to the bottom of the vessel, which 
took about 24 hours. To prevent tissue damage during freezing, the brains were dehy-
drated in 30 % sucrose solution for 72 hours at 4°C. 
The brains were divided into two halves at the interhemispheric fissure, and placed  for 
freezing into a box with dry ice for 5 min. Jung Tissue freezing medium was used to 
fixate each brain hemisphere with the help of the Leica cryostat onto an object holder. 
With the Leica cryostat coronary serial brain sections with 30 µm thickness were creat-
ed from the right half of each brain. The left half of the brains was used for sagittal sec-
tions. The chamber and slide temperature was -20°C to -25°C. Coronary brain sections 
were collected from the following anatomical regions: OB, striatum, HC and substantia 
nigra. For each brain 10 series were sorted and stored in cryo-tubes in antifreeze solu-
tion at -20°C.  
5.5 Tissue staining 
5.5.1 Cresyl violet staining 
The cresyl violet method uses a basic aniline dye to stain RNA blue, and is used to 
highlight important structural features of neurons. The Nissl substance (rough endo-
plasmic reticulum) appears dark blue due to the staining of ribosomal RNA, giving the 
cytoplasm a mottled appearance.  
The fixed brain tissue sections were mounted onto gelatinized glass slides and dried 
for at least 12 hours. Then they were stained in 0.1% cresyl violet for 4 min. Afterwards 
a quick rinse with demineralized water was done, to remove excess stain. Subsequent-
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ly sections were put into 70 % ethanol for 1 min and then for 1-2 min in glacial acetic 
acid (2 drops glacial acetic acid in 95 % ethanol). Then the slides underwent subse-
quent rinses in ethanol in ascending concentrations (70 %, 96 %, 100 %) each for 5 
minutes. Finally, sections were washed twice in xylene for 5 min. 
5.5.2 Immunhistochemical staining 
The principle of the immunohistochemical staining is based on a specific antigen-
antibody binding. In general, a primary antibody is used to detect its specific antigen in 
the tissue sample. Several options are possible to visualize bound antibodies for mi-
croscopy. Two different marker systems were used in this study. 
In the fluorescent method, a secondary fluorochrome-labeled antibody was added, 
which is directed against the Fc-part of the first specific antibody. Fluorochromes ab-
sorb and emit light at defined wavelengths and can be visualized using a fluorescence 
microscope.  
The 3,3'-diaminobenzidine (DAB) staining, however, is an enzyme-based method. In 
this method, the secondary antibody is biotinylated. A so-called tertiary reagent; “ABC”-
(avidin-biotin-complex) is used. It contains biotinylated avidin. Because avidin has a 
high affinity for biotin (over one million times higher than antibodies for most antigens), 
the binding of avidin to biotin is essentially irreversible. In addition, avidin has four bind-
ing sites for biotin. These properties allow macromolecular complexes to be formed 
between avidin and biotinylated enzymes. The enzyme used to visualize bound anti-
bodies is a peroxidase. The secondary biotinylated antibody serves as a bridge be-
tween the primary antibody and the avidin-biotin-enzyme complex. This binds to the 
biotin on the Fc part of the secondary antibody. DAB is a widely used chromogen for 
immunoperoxidase staining. The peroxidase reacts with 3 % hydrogen peroxide sub-
strate to degrade it, which in turn reacts with DAB to precipitate it at the positive sites 
giving dark brown color. The result can be observed with a light microscope. In order to 
prevent false positive results in this enzyme-based staining the endogenous peroxi-
dase was quenched. To this end, the tissues were incubated in a solution of 12.5 % 
methanol peroxidase.  
All immunohistochemical stainings were performed by using the "free floating" tech-
nique. For this purpose multi-wells with mesh inserts were used. Incubation in the re-
spective medium and washing were carried out using a shaker, which guaranteed a 
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constant movement of the sections in the liquid. In order to ensure adequate cleaning 
after each incubation step, the sections were washed five times for five minutes in 0.1 
M PB solution between each incubation step. 
5.5.2.1 Bromodeoxyuridine  
Because the BrdU epitope is hidden within the DNA under non-denaturing conditions, 
DNA was denatured prior to immunostaining. For that purpose, the sections were incu-
bated for 30 minutes in 2 N HCl at 37°C. Thereafter, slices were washed in 0.1 M PBS 
5 times for five minutes. The primary antibody, rat anti-BrdU (OBT0030), was used in a 
concentration of 1 / 500, the secondary antibody, donkey anti-rat (711065152), in a 
concentration of 1 / 500. 
Brain sections including the OB, striatum and HC were stained according to the follow-
ing protocol: 
Washing 4 x 5 min in 3 ml 0.1 M PB shaking   
Quenching endogenous peroxi-
dase activity in methanol peroxi-
dase solution  
15 min at RT in 3 ml of methanol peroxidase solution 
(e.g. 4 ml methanol 100 %, 4 ml H2O2 35 %, 34 ml 0.1 
M PB) 
Washing 4 x 5 min in 3 ml 0.1 M PB shaking   
DNA denaturation  30 min in 2 N HCl in a 37 °C water bath 
Washing in 0.1 M borate buffer, 
pH 8.5  
2 x 5 min in 0.1 M sodium borate buffer (MW 381.4)   
3.8 g + distilled water 100 ml, mix to dissolve and adjust 
pH to 8.5 
Washing 4 x 5 min in 3 ml 0.1 M PB shaking   
Blocking in 5 % Normal Goat Se-
rum (NGS)  
2 h at RT in 3 ml of 5 % NGS solution (9.5 ml 0.3 % 
Triton/0.1 M PB + 0.5 ml NGS) 
Primary antibody:  
Rat anti-BrdU  
(AbD, Serotec  OBT0030; 1:500)  
Incubation overnight at 4 °C in 1 ml of antibody solution 
(1 ml PB/NGS + 2 µl primary antibody) 
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Washing 5 x 5 min in 3 ml 0.1 M PB shaking   
Secondary antibody:  
Donkey anti-rat biotinylated,  
(Jackson ImmunoResearch, 712-
065-150, 1:500)  
Incubation for 60 min at RT in 1 ml of biotinylated sec-
ondary antibody solution (e.g. 10 ml 0.3 % Triton/0.1 M 
PB + 20 µl secondary antibody) 
Incubate in ABC solution ~1:200 Incubation for 60 min at RT in 1 ml of ABC solution (e.g. 
5 ml 0.1 M PB + reagent A 1-drop + reagent B 1-drop) 
Washing 4 x 5 min in 3 ml 0.1 M PB shaking   
Incubate in DAB 
 
Incubation for 2 min in DAB solution (1 ml DAB, 9 ml 0.1 
M PB, 0.2 ml 1 % H2O2 (50 µl sol 30 % H2O2, 1450 µl 
deionized water)) 
Mounting on slides, dehydration and coverslipping 
Table 2: BrdU staining protocol  
5.5.2.2 BrdU/NeuN/TH triple staining 
NeuN (neuronal nuclei) is a neuron-specific DNA-binding nuclear protein which func-
tions as a marker for neurons. NeuN immunoreactivity is observed in post-mitotic neu-
rons that are initiating cellular and morphological differentiation. Tyrosine hydroxylase 
(TH) is the rate limiting enzyme for the production of catecholamines, in particular for 
dopamine. Therefore it is suitable to mark dopaminergic cells.  
Brain sections including the OB, striatum and HC were stained according to the follow-
ing protocol: 
Washing 4 x 5 min in 3 ml 0.1 M PB shaking   
Quenching endogenous peroxi-
dase activity in methanol perox-
idise solution  
15 min at RT in 3 ml of methanol peroxidase solution 
(e.g. 4 ml methanol 100 %, 4 ml H2O2 35 %, 34 ml 0.1 
M PB) 
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Washing 4 x 5 min in 3 ml 0.1 M PB shaking   
DNA Denaturation  30 min in 2 N HCl at 37 °C water bath 
Washing in 0.1 M borate buffer, 
pH 8.5  
2 x 5 min in 0.1 M sodium borate buffer (MW 381.4) 3.8 
g + distilled water 100 ml, mix to dissolve and adjust pH 
to 8.5) 
Washing 4 x 5 min in 3 ml 0.1 M PB shaking   
Blocking in 5 % Normal Goat 
Serum (NGS)  
2 h at RT in 3 ml of 5 % NGS solution (9.5 ml 0.3 % Tri-
ton/0.1 M PB + 0.5 ml NGS) 
Primary antibody: BrdU 
Rat anti-BrdU  
(AbD, Serotec  OBT0030, 1:500)  
Incubation overnight at 4 °C in 1 ml of antibody solution 
(1 ml PB/NGS + 2 µl primary antibody) 
Washing 5 x 5 min in 3 ml 0.1 M PB shaking   
Secondary antibody 
goat anti-rat IgG  
(Alexa Fluor 488, Invitrogen, 
A11006, 1:1000 ) 
Incubation for 2 h at RT in 1 ml of light sensitive second-
ary antibody solution (1 ml PB/NGS + 1 µl AB) (Staining 
was performed under light protection from here on) 
Washing 5 x 5 min in 3 ml 0.1 M PB shaking   
Primary antibody NeuN 
Mouse anti-NeuN  
(Millipore; MAB377B ; 1 :1000)  
 
Incubation overnight at 4 °C in 1 ml of primary antibody 
solution (1 ml PB/NGS + 1 µl NeuN AB) 
Washing 5 x 5 min in 3 ml 0.1 M PB shaking   
Secondary antibody 
Goat anti-mouse Cy3  
(Jackson Immunologicals  
PB/NGSX 115-166-062, 1:500,) 
Incubation for 2 h at RT in 1 ml of light sensitive second-
ary antibody solution (1 ml PB/NGS + 2 µl AB) 
Washing 5 x 5 min in 3 ml 0.1 M PB shaking   
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Primary antibody TH 
Rabbit anti-TH 
(Chemicon AB152, 1; 1000)  
Incubation overnight at 4 °C in 1 ml of primary antibody 
solution (1 ml PB/NGS + 1 µl TH AB) 
Secondary antibody 
Donkey anti-rabbit Cy5  
(Jackson Immunologicals)  
PB/NGSX 1:500, 711-175-152 
Incubation for 2 h at RT in 1 ml of light sensitive second-
ary antibody solution (1 ml PB/NGS + 2ul AB) 
Washing 5 x 5 min in 3 ml 0.1 M PB shaking   
Mounting in a 0.9 % saline pool; Coverslipping after 3-5 min with DABCO (1,4-Diazabicyclo-
octane) mounting medium  
Table 3: Triple staining protocol 
5.6 Microscopic analysis 
5.6.1 Qualitative evaluation of cresyl violet  
In order to evaluate the quality of the tissue sections, the cresyl violet stained sections 
were screened under a light microscope to assess, whether the perfusion was carried 
out properly.  
5.6.2 Stereology 
For the quantification of cells, the Nikon Microphot FX (Nikon Shinjuku, Tokyo, Japan) 
together with a semi-automatic stereology system Stereoinvestigator (MicroBrightField 
Bioscience, Williston, VT, USA) were used. The analysis was done by an observer 
blinded to the treatment of the animals. The counting of immunohistochemically stained 
cells in the DAB-staining technique was carried out on every 10th coronal section. The 
number of positively stained cells was estimated with an optical fractionator by using 
systematic random sampling of the sections of interest in order to yield the approximate 
number per anatomical region. The regions taken for counting were defined according 
to “The Mouse Brain in Stereotaxic Coordinates” (2nd edition, Paxinos and Franklin, 
2001). The reference volume was defined by manual tracing of the regions of interest 
with the semiautomatic stereology system. The system works with a light microscope 
equipped with a motorized stage interfaced with a video camera and a PC. Regions to 
be counted are manually defined with a 10 x objective. The program then generates 
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unbiased counting grid of 100 x 100 µm with a 40 x objective. Positive cells within the 
frame are marked by the investigator manually. All positive cells in the accordant region 
were counted. A cell was defined as positive and counted when fulfilling the following 
criteria: evenly stained, complete, sharply bounded nuclei with a dark brown color. Pos-
itive profiles that intersected the uppermost focal plane (exclusion plane) or the lateral 
exclusion boundaries of the counting frame were not counted. All sections of one series 
were counted by the same investigator to minimize investigator-related-bias. When 
finished with counting the system automatically moves the total counting grid to the 
next frame so that the predefined traced regions are systematically screened. The es-
timated cell count is calculated by the system. Therefore the total counts of marked 
cells are multiplied by the ratio of reference volume and sampling volume and thereby 
the total cell number is mathematically estimated. 
5.6.2.1 BrdU immunhistochemical staining 
SVZ: For counting BrdU+ cells in the SVZ coronal sections were analyzed. To define 
the SVZ-region, the atlas shown in Fig. 12 was used. All BrdU+ cells in this region were 
counted (Fig. 13). 
 
Fig. 12: Atlas of the SVZ. The SVZ is highlighted in red color. scale bar: 2 mm 
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Fig. 13: SVZ in a BrdU-stained brain section of an experimental mouse. The SVZ is high-
lighted in the red panel. scale bar: 1 mm 
SGZ: For counting BrdU+ cells, the SGZ of the dentate gyrus of the HC was analyzed 
in coronal sections. Only cells in the subgranular layer, which is located at the very 
bottom of the granular layer, were counted. To define SVZ-region, the atlas shown in 
Fig. 14 was used. Fig. 15 shows on a BrdU-immunostained section, which cells belong 
to the SGZ. 
 
Fig. 14: Atlas of the SGZ in the dentate gyrus of the HC. The SGZ is highlighted in red color.  
scale bar: 2 mm 
METHODS	
	
	
	 	 	
51	
 
Fig. 15: Dentate gyrus of the HC in the brain slice of an experimental mouse. The green 
arrows point the stained cells in the subgranular layer. These were counted. The red arrows 
indicate a cell outside the subgranular layer (molecular layer). These were not counted. scale 
bars: a) 1 mm; b) 500 µm 
OB: BrdU+ cells were counted in the granular and periglomerular region in the OB. This 
is illustrated in Fig.16.  
a) 
b) 
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Fig. 16: Areas of quantification in the OB.  
a) Overview over the OB. (GCL= Granular cell layer, GL= Glomerulus, MCL= Mitral cell layer, 
EPL= External plexiform layer) b) Schematic drawing of areas included into quantification of 
BrdU+ cells in the OB (RMS = rostral migratory stream, blue frame = quantification of peri-
glomerular cells, red area = quantification of granular cells). Pictures modified according to 
(Hack et al., 2005, Saghatelyan et al., 2005) scale bars: a) 1 mm; b) 30 µm 
5.6.2.2  Quantification of triple staining  
The neuronal differentiation of newborn cells in the HC, the granule cell and peri-
glomerular layer of the OB was assessed using triple immunofluorescence labelling for 
BrdU, NeuN and TH. The evaluation was performed on a confocal laser scanning mi-
croscope (Zeiss LSM 510, Oberkochen, Baden-Württemberg, Germany). Confocal mi-
croscopy enables the reconstruction of three-dimensional structures from the obtained 
images. It uses laser light to excite fluorescent dyes and generate digital microscopic 
images of high spatial resolution and strict separation of detection channels. This tech-
nique gives the opportunity to find out whether a newly built (BrdU+) cell is a (NeuN+) 
neuron and if it is from the dopaminergic (TH+) phenotype or not. Coronary sections 
from the HC and the OB were analyzed.  
5.7 Statistical analysis 
Data are reported as the mean ± SEM. Normal parametric data were compared with a 
two-sided unpaired t-test calculated with IBM SPSS Statistics 20.0. A value of p < 0.05 
was considered to be statistically significant. 
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6 RESULTS 
6.1 Proliferation  
For the evaluation of the stem cell proliferation in SVZ and SGZ, 3 months old orex-
in/ataxin-3 (n = 8) and WT mice (n = 8) received a single intraabdominal injection of 
100 mg BrdU/kg body weight 2 h prior to sacrifice and perfusion. The BrdU-
quantification was carried out with microscope using the semi-automatic stereology 
system. 
6.1.1 Proliferation in the subgranular zone of the hippocampus  
In the SGZ of the HC, the BrdU-quantification revealed a significantly higher number of 
newly built cells in the orexin/ataxin-3 mice (103 ± 6) than in WT mice (77 ± 5; p = 
0.008) (Fig. 17). 
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Fig. 17: Comparison of newly built BrdU+ cells, labeled 2 hrs. before sacrifice, in 3 
months old WT and orexin/ataxin-3 mice in the SGZ of the HC. The number of newly built 
cells in orexin/ataxin-3 mice was significantly higher than in WT mice (p = 0.008).  
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6.1.2 Proliferation in the subventricular zone 
In the SVZ, the BrdU-quantification revealed a significantly higher number of new built 
cells in the orexin/ataxin-3 mice (5864 ± 115) than in WT mice (4951 ± 164; p < 0.001) 
(Fig. 18). 
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Fig. 18: Comparison of newly built BrdU+ cells, labeled 2 hrs. before sacrifice, in 3 
months old WT and orexin/ataxin-3 mice in the SVZ. The number of newly built cells in orex-
in/ataxin-3 mice was significantly higher than the number in WT mice (p < 0.001).  
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6.2 Migration  
For the analysis of migrating cells in the RMS, BrdU+ were counted 2 h after injection. 
BrdU-Quantification revealed a tendency for a higher number of newly built migrating 
cells in the RMS of orexin/ataxin-3 mice (817 ± 55) than in WT mice (678 ± 107), which 
did not reach statistical significance (p = 0.221) (Fig. 19). 
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Fig. 19: Comparison of newly built BrdU+ migrating cells, labeled 2 hrs. before sacrifice,  
in 3 months old WT and orexin/ataxin-3 mice in the RMS. The number of newly built cells in 
orexin/ataxin-3 mice (817 ± 55) was higher than the number in WT mice (678 ± 107), but did not 
reach statistical significance (p = 0.221). 
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6.3 Survival 
For the illustration of survival of newly built neurons, BrdU was administered intraperi-
tonially once per day for 5 consecutive days to 3 months old orexin/ataxin-3 (n = 8) and 
WT mice (n = 8). The last injection was made 30 days before the mice were sacrificed. 
6.3.1 Survival in the hippocampus  
Although the BrdU-quantification revealed tendency for a higher number of surviving 
BrdU+ cells in the HC in orexin/ataxin-3 mice (399 ± 29) than in WT mice (311 ± 25), 
the difference was not significant (p = 0.058) (Fig. 20).  
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Fig. 20: Comparison of the surviving newly built BrdU+ cells in the HC of WT and orex-
in/ataxin-3 mice, labeled at an age of 3 months on 5 consecutive days 30 days before 
sacrifice. The number of cells in orexin/ataxin-3 mice (399 ± 29) had a tendency for higher 
numbers than in WT mice (311 ± 25) without reaching significance (p = 0.058). 
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6.3.2 Survival in the granular zone of the olfactory bulb  
In the granular zone of the OB, BrdU-quantification revealed a significantly higher 
number of newly built BrdU+ cells surviving for 30 days in orexin/ataxin-3 mice (14716 ± 
413) than in WT mice (11786 ± 385; p < 0.001) (Fig. 21). 
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Fig. 21: Comparison of newly built BrdU+ cells in the granular zone of the OB in WT and 
orexin/ataxin-3 mice, labeled at an age of 3 months on 5 consecutive days 30 days before 
sacrifice. The number of new built cells in orexin/ataxin-3 mice (14716 ± 413) was significant 
higher than in WT mice (11786 ± 385; p < 0.001). 
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6.3.3 Survival in the periglomerular zone of the olfactory bulb 
The BrdU-quantification revealed no significant difference between the number of new-
ly built BrdU+ cells surviving for 30 days in the periglomerular zone of the OB in orex-
in/ataxin-3 mice (2615 ± 76) and in WT mice (2617 ± 71; p = 0.894) (Fig. 22). 
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Fig. 22: Comparison of the surviving newly built BrdU+ cells in the periglomerular zone of 
the OB of WT and orexin/ataxin-3 mice mice, labeled at an age of 3 months on 5 consecu-
tive days 30 days before sacrifice. No significant difference was found between the cell num-
bers in orexin/ataxin-3 mice (615 ± 76) and that in WT mice (2617 ± 71; p = 0.894). 
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6.4 Differentiation  
Triple immunostaining (BrdU/NeuN/TH) was carried out to assess the percentage of 
newly built BrdU+ cells, which differentiated within 30 days into neurons (NeuN+) in 
general, or into a dopaminergic phenotype (TH+) in particular.  
6.4.1 Differentiation in the hippocampus  
The differentiation of BrdU+ cells into NeuN+ neurons in the HC of orexin/ataxin-3 mice 
(89.50 % ± 1.12 %) was significantly higher than in the HC of WT mice (83.14 % ± 1.99 
%; p = 0.020) (Fig. 23). 
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Fig. 23: Comparison of the percentage of newly built NeuN+ neurons among the newborn 
BrdU+ cells in the HC of WT and orexin/ataxin-3 mice, BrdU labeled at an age of 3 months 
on 5 consecutive days 30 days before sacrifice. The percentage of newly built NeuN+ neu-
rons of all newly built BrdU+ cells in orexin/ataxin-3 mice (89.50 % ± 1.12 %) was significantly 
higher than in WT mice (83.14 % ± 1.99 %; p = 0.020). 
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6.4.2 Differentiation in the olfactory bulb  
No significant difference could be found in the percentage of differentiated neurons 
(NeuN+) and for the percentage of differentiated dopaminergic cells (TH+). The quantifi-
cation of BrdU labeled and BrdU/NeuN double labeled cells revealed, that the percent-
age of differentiated neurons of all new built cells in orexin/ataxin-3 mice (93.63 % ± 
1.44 %) was not significantly higher than the proportion of WT mice (91.29 % ± 1.51 %; 
p = 0.445) (Fig. 24). 
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Fig. 24: Comparison of the percentage of differentiated NeuN+ neurons of all newly built 
BrdU+ cells in the granular zone of the OB in WT and orexin/ataxin-3 mice, labeled at an 
age of 3 months on 5 consecutive days 30 days before sacrifice. The percentage in orex-
in/ataxin-3 mice (93.63 % ± 1.44 %) was not significantly higher than in WT mice (91.29 % ± 
1.51 %; p = 0.445).  
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The quantification of BrdU/TH double labeled cells revealed, that the percentage of 
dopaminergic cells of all newly built cells in orexin/ataxin-3 mice (86.38 % ± 1.36 %) in 
the periglomerular zone of the OB was not significant higher than the proportion in WT 
mice (81.29 % ± 1.71 %; p = 0.088) (Fig. 25). 
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Fig. 25: Comparison of the percentage of dopaminergic TH+ cells of all new built BrdU+ 
cells in the periglomerular zone of the OB in WT and orexin/ataxin-3 mice, labeled at an 
age of 3 months on 5 consecutive days 30 days before sacrifice. The percentage in orex-
in/ataxin-3 mice (86.38 % ± 1.36 %) was not significantly higher than in WT mice (81.29 % ± 
1.71 %; p = 0.088) 
	 DISCUSSION	
	
	
	 62	
7 DISCUSSION 
7.1 Summary and interpretation of the main results 
In this study the regulative role of the neuropeptide orexin on adult neurogenesis was 
investigated. Neurogenesis in adult WT mice was compared to the orexin/ataxin-3 
mouse model, showing a 99 % loss of orexin neurons at the time of investigation.  
Mice of the first group were sacrificed 2 hours after a single BrdU injection. In this 
group, precursor cell proliferation in the SGZ and SVZ was significantly higher in the 
orexin/ataxin3 mouse. Also in the RMS, proliferation rates were slightly higher in the 
absence of orexin, but this difference did not reach statistical significance.  
Mice of the second group were sacrificed 30 days after 5 consecutive daily BrdU in-
jections to investigate survival rates of newly generated cells. A significant difference in 
the granular zone of the OB could be demonstrated. Again the number of newly built 
cells was higher in the orexin/ataxin group. However, this could not be shown for the 
periglomerular zone of the OB. Higher survival rates of new built cells were observed in 
the HC of orexin/ataxin-3 mice, closely missing statistical significance (p = 0.058). Re-
sults are limited by the low cell counts in the HC. In the HC, absolute BrdU+ cell num-
bers range around 100 per HC cell layer, whereas in the granular zone of the OB, the 
BrdU+ cell population ranges between 11.000-15.000 per OB cell layer.  
After finding a higher proliferation and partly higher survival rates in the orexin/ataxin 
group, the influence of orexin on the differentiation of new built cells was investigated 
by triple staining. The proportion of neurons relative to the total number of new built 
cells in the HC was significantly higher with 90 % in the orexin/ataxin group compared 
to 83 % in the control group. Hence it may be concluded for the HC that in the absence 
of orexin a higher proportion of new built cells differentiates into neurons as the total 
number of new built cells was not influenced. 
No significant difference (p = 0.445) in the number of newly born neurons relative to the 
total number of newly built cells could be found in the granular zone of the OB (94 % in 
orexin/ataxin-3 mice, 91 % in the WT group). 
Since it is known, that almost all granule cells are GABAergic (Mugnaini et al., 1984), 
the proportion of dopaminergic cells was examined only for the periglomerular zone, 
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where a differentiation into both GABAergic and dopaminergic phenotypes is known. A 
higher trend of dopaminergic differentiation could be seen in the periplomerular zone of 
the OB of the orexin/ataxin-3 mice, but the proportion of dopaminergic cells of all new 
built cells in orexin/ataxin-3 mice was not significantly higher than in WT mice. 
Taken these results together, it can be assumed that orexin suppresses the prolifera-
tion of the adult NSC, affects the survival rate in the OB negatively and hinders the 
differentiation of new built cells into neurons in the HC. 
7.2 Discussion of methodological correctness 
7.2.1 Study size 
The biometric experimental design of this study is based on the experience of our 
group in this area (Hoglinger et al., 2004) and on the need to collect statistically rele-
vant data.  In both groups we studied n = 8 mice. Although an exclusion rate of 15 % 
was calculated previously in the given number, all mice could be successfully evaluat-
ed and included into analysis. With the given study size significant results turned out for 
the proliferation rate in the SVZ and SGZ, for the survival rate in the granular zone of 
the OB and for the differentiation in the HC. In the case of the survival rate in the peri-
glomerular zone of the OB and the differentiation in the OB the study size was suffi-
cient to identify differences, but too small to make clear statements for all of these pa-
rameters. For this purpose the study should be repeated with a larger population.  
7.2.2 Suitability of the orexin/ataxin-3 mouse model 
Is the orexin/ataxin-3 mouse a suitable model to investigate the influence of orexin on 
adult neurogenesis? Advantages and disadvantages compared to other mouse models 
will be addressed in the following section.  
Advantages: The selected orexin/ataxin-3 mouse model does not require subsequent 
interventions, such as externally applied chemical or mechanical ablation of orexinergic 
neurons. Postnatal interventions often lead to a greater source of error than genetically 
modified mouse models. Consequently comparability to WT mice is often limited.  
Compared to the knock-out mouse a decisive advantage exists for the orexin/ataxin-3 
mouse model, which is due to the different development of the mice. In the knock-out 
mouse the entire embryonic brain development occurs without orexin. Thus, this organ-
ism may adapt to the lack of orexin and uncontrolled compensatory mechanisms may 
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emerge. Probably, this will not be without consequences for the regulatory mechanisms 
of the later adult neurogenesis.  
Another thinkable way of determining the role of orexin on the adult neurogenesis is the 
use of an orexin receptor antagonist. However, if the orexin-effect is switched off by the 
use of antagonists, a compensatory up-regulation of the receptor numbers is likely to 
occur. Thus, this model would be less reliable in comparison. 
Disadvantages: In contrast to the knock-out mouse, the orexin-ataxin-3 mouse loses 
all its orexin-containing neurons. Beside orexin these neurons produce galanin, angio-
tensin and the endogenous opiate dynorphin (Chou et al., 2001). Even if these pep-
tides are still produced by other cells in the brain (Kaplan et al., 1988), their quantity 
and site of action is changed, which might have unknown effects neuronal homeosta-
sis. Controversially to orexin, a promotional effect on neuronal differentiation in murine 
subventricular zone cell cultures could be shown for galanin (Agasse et al., 2013). It 
has been shown, that an increased concentrations of angiotensin in the systemic circu-
lation during exercise may promote neurogenesis in the adult rat HC (Mukuda et al., 
2014). Currently there are no scientific studies of dynorphin and adult neurogenesis. 
Thus it is not excluded that the reduced occurrence of galanin, angiotensin or dy-
norphin may bias the present results.  
Since progressive loss of orexin neurons is due to apoptosis induced by a toxic gene 
product, the increased proliferation might also be a result of a general inflammatory 
reaction caused by the apoptotic process. This issue will be addressed further below. 
7.2.3 Reliability of BrdU to label newborn cells 
At present, essentially all in vivo studies on adult neurogenesis rely on the BrdU meth-
od for quantification of newly built cells. BrdU as a synthetic analogue of thymidine, is 
incorporated in the cellular DNA of proliferating cells in the S phase of mitosis and can 
be subsequently detected by immunohistochemistry. For detection of adult neurogene-
sis BrdU is considered as the gold standard (Vega and Peterson, 2005). The most criti-
cal aspect of using BrdU as a proliferation marker is the suspicion that it labels not only 
dividing cells but also marks dying or damaged cells. Cooper and Kuhn could show that 
BrdU may be incorporated not only in dividing cells, but also in any cell effecting DNA 
synthesis, including DNA repair. Several experimental data argue against the concern 
that the concentration, in which BrdU is commonly used, may be sufficient to detect 
cells undergoing DNA repair (Cooper-Kuhn and Kuhn, 2002). The group around 
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Cooper-Kuhn combined BrdU and labeling methods for apoptosis to argue against 
DNA repair being a major contribution of BrdU+ cells. They could show that apoptotic 
cell death, which is accompanied by activation of DNA repair mechanisms, is not la-
beled by BrdU incorporation.  
However, subsequent investigations showed contradictive results confirming that BrdU 
may label apoptotic cells as well (Hoglinger et al., 2007). Consequently, the number of 
apoptotic cells should be co-examined in the investigated areas, to ensure that the rate 
of apoptotic cells is negligible in relation to the newborn cells. 
As an alternative method integration of a retroviral genome into the chromosomal DNA 
is used to detect cell proliferation. The stable integration of the retroviral genome into 
the chromosomal DNA can only occur after nuclear membrane breakdown. Expression 
of viral genes in infected cells is therefore only present in cells that have undergone 
mitosis. Retroviral labeling, therefore, distinguishes between cell division and DNA re-
pair. In contrast to the BrdU labeling, the viral DNA gets transferred reliably to each 
daughter cell. But several disadvantages make retroviral infection less suitable for in 
vivo applications. Retrovirus particles have to be directly applied to the CNS region of 
interest, since the blood–brain barrier is an impermeable obstacle. Consequently, le-
sion-induced effects on neurogenesis have to be taken into account when studying 
stem cell activity in the intact brain. In addition, the method is more technically demand-
ing and costly than BrdU labeling. Nevertheless it is a secure method to confirm results 
obtained with BrdU labeling (Cooper-Kuhn and Kuhn, 2002).  
7.2.4 The first paradigm – proliferation of progenitor cells 
For the evaluation of the stem cell proliferation in SVZ and SGZ, orexin/ataxin-3 mice 
and WT mice received a single intraperitoneal injection of 100 mg BrdU/kg body weight 
2 hour prior to sacrifice. A crucial variable in the analysis of BrdU labeling studies is the 
time the tracer is injected in relation to the time of scarification (Prickaerts et al., 2004). 
In the first paradigm the selected moment for sacrifice after BrdU injection attempts to 
ensure that only proliferating progenitor cells are labeled. It has been shown, that pro-
liferation should be measured using a protocol in which subjects are treated with a 
tracer and killed maximally within 24 h after injection (Hayes and Nowakowski, 2002). 
This is due to the fact, that BrdU has a bioavailable time for incorporation of only about 
30–60 min, thus immediately after injection almost all S-phase cells are labeled 
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(Boswald et al., 1990). Each newly made cells can then either remain in proliferation 
mode and continue to divide or can migrate out of the proliferation zone and either dif-
ferentiate or die. It is known, that in the days after a single BrdU administration, the 
numbers of BrdU+ cells increase peaking at around 1 week post-injection (Gould et al., 
1999). The total number of cells counted at any time point, except for 1–2 h after the 
label injection, is a summation of proliferation at the time of injection plus proliferation 
on each day after injection less the death rate of the newly made cells.  
The selected dose of 100 mg BrdU/kg body weight has been chosen because BrdU 
doses of 50–100 mg/kg BrdU body weight are sufficient to label the vast majority of S-
phase proliferative cells in mice (Burns and Kuan, 2005). It has been reported that sin-
gle doses of BrdU 100, 50 and 25 mg/kg body weight labels 60 %, 45 % and 8 % of S-
phase cells in adult rat DG, respectively. Doses greater than or equal to 300 mg/kg 
body weight are needed to label most S-phase cells, as the number of BrdU-labeled 
cells appeared to plateau (Cameron and McKay, 2001). Nevertheless BrdU is a toxic 
substance at much higher doses. It has been that the chosen dose of 100 mg/kg body 
weight is sufficient and safe to use in rodent for studying adult neurogenesis without 
inducing relevant toxic effects (Sekerkova et al., 2004). 
7.2.5 The second paradigm – survival and differentiation of progenitor 
cells 
For the analysis of differentiation and survival of newly built neurons, BrdU was admin-
istered intraperitoneally on 5 consecutive days once per day to each mouse. The mice 
were sacrificed 30 days after the last injection. The neuronal differentiation of newborn 
cells in the HC, the granular and periglomerular zone of the OB was assessed using 
triple immunofluorescence labeling for BrdU, NeuN and TH. Choosing the right time 
after the administration of BrdU is fundamentally important to draw a reliable conclu-
sion for survival and differentiation rates of newly formed cells. It is apparent from 
quantitative studies that approximately 50 % of newly formed cells die within the first 
two weeks of life in both neurogenic zones (Petreanu and Alvarez-Buylla, 2002).  
For the region of the HC, one study indicates that the quantification of BrdU+ cells per-
mits a reliable estimation of survival rate four weeks after administration of the prolif-
eration marker (Kempermann et al., 2003). According to these results, the second par-
adigm is reliable to mark the survival rate of newly formed cells in the HC.  
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Moreover Winner and colleges (2002) examined the long-term effects of adult neuro-
genesis in the OB. These data show that a peak of BrdU+ cells was reached in the ol-
factory bulb 1 month after BrdU injection, when all new cells have finished migrating 
from the ventricle wall. However, the number of BrdU+ cells in the region of the OB no 
longer significantly changed from the end of the third month up to a period of 19 
months after administration of BrdU (Winner et al., 2002). Moreover, dopaminergic dif-
ferentiation in the periglomerular zone was first visualized one month after BrdU injec-
tion, however the peak of dopaminergic differentiation occurred three month after BrdU 
injection. Thus, the influence of orexin on the dopaminergic differentiation could be 
examined more reliable after three months. In the present study dopaminergic differen-
tiation was investigated after one month. Thus, the rate of dopaminergic differentiation 
may have been underestimated and the differences between groups were not yet visi-
ble. For investigations in the OB the chosen date of sacrifice gives the advantage that 
due to the peak of new built cells after one month it is statistically more likely to meas-
ure a difference between the two experimental groups. This also applies to the neu-
ronal differentiation, which reaches its peak at the same time (Winner et al., 2002). The 
set time point of investigation yields the disadvantages that no prediction can be made 
for long-term-survival of new built cells. For that propose, the examination was carried 
out to early.  
Furthermore it should be taken to account, that the dying of progenitor cells was not 
analyzed in this work. It is known, that about 50 % of proliferating progenitor cells die. 
Especially young and immature cells are under pressure of elimination by programmed 
cell death (Biebl et al., 2000). It is therefore useful to measure apoptosis in order to 
determine to what extent changes in survival reflect differences in apoptotic rates 
(Young et al., 1999). Biebl and colleges analyzed programmed cell death using the 
TUNEL-assay, which labels fragmented DNA with tagged nucleotides. They conclude 
that programmed cell death may have an important regulatory function by eliminating 
supernumerous cells from neurogenic regions and may thus contribute to a self-
renewal mechanism in the adult mammalian brain (Biebl et al., 2000).  
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7.3 Effect of orexin depletion in neurogenic regions 
In the absence of orexin in the adult mouse brain, the proliferation of adult NSC was 
increased, the survival rate was significantly increased in the granular zone of the OB 
and a consistent not significant trend was seen in the HC.  
Regarding the results of this study so far it is not possible to judge whether the influ-
ence of orexin on neurogenesis is due to either direct effects on neural adult stem cells 
or indirect effects by interacting with other neurotransmitters. In addition, the orex-
in/ataxin-3 mouse model mimics a neurodegenerative process. Therefore, changes of 
adult neurogenesis could be caused by mediators of neuroinflammation. 
7.3.1 Direct effects of orexin on progenitor cells  
Since a high density of orexin afferents in the SVZ has been shown previously 
(Alvarez-Buylla and Lim, 2004, Lledo et al., 2006) and a direct, topographically orga-
nized innervation of the SVZ and SGZ by orexin neurons and orexin receptor expres-
sion on adult NSC has been shown by Arias-Carrión (pictures above) a direct effect of 
orexin on the progenitor cells within the SGZ of the HC and SVZ appears to be likely. 
7.3.2 Indirect effects of orexin on progenitor cells 
Orexin cells widely project to various neurotransmitter systems, which also evidently 
influence adult neurogenesis. Therefore, indirect ways of orexinergic effects on neuro-
genesis have to be taken into account. Orexin fibers project to the brain stem, specifi-
cally to the noradrenergic locus coeruleus, the serotonergic raphe nuclei and the do-
paminergic substantia nigra (Peyron et al., 1998). The dopaminergic VTA receives an 
input from orexin neurons (Korotkova et al., 2003). Orexin generally exerts excitatory 
actions (Nishino and Sakurai, 2006). 
Extensive noradrenergic projections reach the dentate gyrus from the locus coeruleus 
(Loy et al., 1980). Previous results have indicated, that depletion of noradrenaline de-
creases the proliferation, but does not influence the survival or differentiation of adult 
hippocampal granule cell progenitors (Kulkarni et al., 2002). By identifying these rela-
tionships it becomes clear that adult neurogenesis in the HC may actually be enhanced 
by the excitatory effect of orexin on noradrenergic neurons.  
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Serotonergic afferents project from the raphe nuclei in the brain stem to the SGZ and 
serotoninergic input was found to increase adult neurogenesis in the HC and the SVZ 
(Brezun and Daszuta, 1999). Therefore, another indirect way of orexin on neurogene-
sis can be derived via serotonin. Orexin neurons send excitatory projections to sero-
tonergic neurons in the raphe nuclei (Hagan et al., 1999, Brown et al., 2001). Conse-
quently, one would expect via strengthening the action of serotonin, analogous to nor-
adrenaline, a proliferative indirect effect by orexin.  
Experimental depletion of dopamine in rodents decreases precursor cell proliferation 
in both the subependymal zone and the subgranular zone. Experiments with neural 
precursors from the adult subependymal zone grown as neurosphere cultures confirm 
that activation of D2-like receptors directly increases the proliferation of these precur-
sors (Hoglinger et al., 2004). Orexin directly activates VTA dopaminergic neurons 
(Korotkova et al., 2003), this might enhance the proliferative effect of dopamine on pre-
cursor cells. 
An indirect effect of orexin via the serotonergic and dopaminergic projections is not 
likely with the results of this study. However, an indirect effect via noradrenaline on 
precursor cell proliferation seems likely. Considering the complexity of the brain, addi-
tional indirect effects of orexin on adult neurogenesis by interaction of various neuro-
transmitters seem to be possible. Further studies are needed to give evidence for these 
mechanisms. For example, a study design with an experimental depletion of the nora-
drenergic, dopaminergic or serotonergic system in the orexin/ataxin-3 mice would be 
an interesting approach.  
7.3.3 Role of inflammatory mediators on adult neurogenesis 
The orexin/ataxin-3 mouse mimics a neurodegenerative condition. Since progressive 
loss of orexin neurons is due to apoptosis induced by a toxic gene product, the in-
creased proliferation might also be a result of the general inflammatory reaction caused 
by the apoptotic process. 
It could be shown for example that stroke caused by transient middle cerebral artery 
occlusion in adult rats, leads to a marked increase of cell proliferation in the SVZ 
(Arvidsson et al., 2002). In another study, SVZ neurospheres were maintained in the 
presence of diffusible signals derived from the non-neurogenic cerebral cortex either 
previously treated with the apoptosis inducer staurosporine or not. Increased cell prolif-
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eration could be shown in the SVZ neurosphere which was maintained in the presence 
of factors derived from cortex with apoptotic damage (Agasse et al., 2004). One im-
portant component in these pathological environments is the process of inflammation 
(Kerschensteiner et al., 2009). With its diversity of cell types and activation states, the 
inflammatory reaction could be everything from detrimental to supportive for adult neu-
rogenesis (Simard and Rivest, 2004). A major player is the innate microglia. Microglia 
activation, as an indicator of inflammation, is not pro- or antineurogenic per se but the 
net outcome is dependent on the balance between secreted molecules with pro- and 
antiinflammatory action (Ekdahl et al., 2009). It has been shown that transgenic over-
production of interleukin-6 by astroglia is sufficient to decrease overall neurogenesis by 
63 % in the hippocampal dentate gyrus of young adult mice (Vallieres et al., 2002). 
Moreover, it could be demonstrated that lipopolysaccharide administration inhibits neu-
rogenesis in the HC, which can be restored by a non-selective cyclooxygenase inhibitor 
(Monje et al., 2003). On the other hand, other inflammatory molecules have a plei-
otropic role in neurogenesis, at least for neural progenitor cells prepared from embry-
onic rat HC (Harada et al., 2004). Thus, the innate immune response in the brain is 
able to positively or negatively modulate neurogenesis in the CNS depending on the 
cytokines and growth factors that are predominantly expressed in the cellular environ-
ment.  
In order to assess, the impact of the apoptotic process on the present results the ex-
perimental setup has to be considered. In the used orexin/ataxin-3 mouse model a 99 
% loss of orexin cells was observed after 12 weeks and any orexin cell in the lateral 
hypothalamic region could hardly be detected after 15 weeks (Hara et al., 2001). In the 
present study BrdU was injected when mice were aged between 96 and 127 days, at 
the chosen time the major part of the apoptotic process of orexin neurons was already 
over. However, differences in adult neurogenesis may be biased by a still ongoing in-
flammatory apoptotic process, which has not been controlled for.   
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7.4 Influence on differentiation in the olfactory bulb and in the hippo-
campus 
Given that multipotent precursor cells can give rise to neuronal and glial cell types in a 
characteristic order of birth, it is clear that precursor cell proliferation must be precisely 
regulated. Several intrinsic factors expressed by stem cells and progenitors control 
both proliferation rates and the fate of newborn cells. In addition, external factors such 
as neurotransmitters, hormones and growth factors might cooperate with intrinsic pro-
grammes to modulate these processes (Lledo et al., 2006). In order to understand the 
regulatory mechanism underlying neuronal differentiation, it is important to determine 
the types of neural inputs on adult progenitor cells and their physiological effects.  
By triple staining it could be demonstrated that neuronal differentiation in the HC was 
significantly higher with 90 % in the orexin-ataxin group compared to 83 % in the con-
trol group. Since there is a significantly higher neuronal differentiation in the absence of 
orexin, one can assume an inhibitory effect of orexin on neuronal differentiation. It 
seems reasonable to proof whether orexinergic neurons act directly on adult hippo-
campal progenitor cells. Little information exists regarding the neural connections be-
tween orexin cells and the hippocampal network. As mentioned above, a direct inner-
vation of the SGZ in the HC has been indicated by our group (unpublished data see 
above). By immunofluorescence labeling for orexin A and the OX2R the co-localization 
of orexin neurons and nestin-GFP labeled adult NSC or proliferating progenitor cells 
could be illustrated using a confocal laser scanning microscope. 
So far research in the field of adult neurogenesis primarily focused on exogenous 
factors influencing proliferation, migration and survival. Little information exist for 
differentiation of new born cells in the HC. The best evidence as exogenous regulating 
neurotransmitter for the neuronal differentiation in the HC exists for GABA. It has been 
demonstrated, that GABAergic inputs to hippocampal progenitor cells promote activity-
dependent neuronal differentiation. More precisely, excitation of adult hippocampal 
progenitor cells by activated GABA receptors initiated a calcium influx. This subse-
quently induced the accumulation of the neurogenic transcription factor, NeuroD. In-
deed, NeuroD is required for differentiation of the granule cells in the dentate gyrus of 
the hippocampus (Liu et al., 2000). Moreover, a BrdU-pulse labeling study with GABA 
receptor agonists demonstrated the promotion of neuronal differentiation via GABAer-
gic excitation (Tozuka et al., 2005). As there is no evidence for connections between 
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orexin and GABA, orexinergic influence on neuronal differentiation in the HC via 
GABAergic interneurons remains speculative. 
In the granular zone and in the periglomerular zone of the OB over 90 % of the total 
amount of new built cells differentiated into neurons in both groups. There was no sig-
nificant difference. The rate of dopaminergic differentiation in the periglomerular zone 
of the OB of the orexin/ataxin-3 mice compared to WT mice was also not significantly 
changed.  
With regard to the regulation of neuronal and dopaminergic differentiation in SVZ, the 
given data are still sparse. It is assumed that, SVZ progenitors give rise to different OB 
interneuron types in accordance to their position along the ventricles (Merkle et al., 
2007). However, it is still debated to which extent this co-relation between progenitor 
position and neuronal type generated is due to an internal program or distinct environ-
mental factors impinging onto progenitors (Sequerra et al., 2013). Although we have 
some information on the internal programs of different interneuron subtypes and about 
their site and time of origin, little is known about external factors. It is already known, 
that SVZ neurogenesis is regulated by the olfactory experience of animals (Lledo et al., 
2006). Moreover, development of OB dopaminergic phenotypic expression specifically 
required particular patterned activity from olfactory receptor cells (Baker and Farbman, 
1993, Puche and Shipley, 1999). In the field of neurotransmitters, it could be already 
shown, that dopamine depletion impairs precursor cell proliferation (Baker et al., 2004, 
Hoglinger et al., 2004), but there is no evidence about influence on neuronal or dopa-
minergic differentiation.  
First descriptions about the distribution of orexin fibers found less prominent orexiner-
gic projections in the OB (Peyron et al., 1998). Our group could also illustrate orexin 
fibers and receptors in the SVZ, RMS and in the OB. 
The present results indicate that in the absence of orexin the rate of dopaminergic dif-
ferentiation is not changed. Still the orexinergic innervation of the SVZ, RMS and OB is 
evident. Understanding the mechanisms underlying the development of dopaminergic 
cells is relevant to the research of restorative therapy for Parkinson's disease (Baker et 
al., 2001). To prove the role of orexin in neuronal and dopaminergic differentiation fur-
ther studies are needed. 
	 DISCUSSION	
	
	
	 73	
7.5 Functional relevance of orexin on adult neurogenesis 
To discuss the role of orexin for adult neurogenesis it is important to assess the mean-
ing, possible benefit and biological relevance of new built cells. The common percep-
tion is that new neurons in the adult brain would be beneficial. However, during evolu-
tion, the amount of adult neurogenesis decreases with increasing brain complexity. 
Whereas lower vertebrates, such as lizards, can regenerate entire brain parts, neuro-
genesis in adult mammals is restricted to a few regions (Kempermann et al., 2004b). 
Thus, not only quantitative proliferation rates, but mainly functional integration of new 
built cells into existing brain circuitries appears to be relevant. Functional integration is 
considered to be a result of increased proliferation rate and a consequent impact on 
the behavioral or cognitive level. This can be addressed experimentally in form of be-
havioral experiments. An example to prove the functional integration of new built cells 
in the HC is shown by Kempermann and Gage (2002). They found a significant correla-
tion between the number of new neurons generated in the dentate gyrus and parame-
ters describing the acquisition of new memories in the water maze task. In order to 
evaluate the functional integration of the newly built cells in the ataxin/orexin-3 mouse, 
behavioral experiments of this kind have been conducted in a parallel study, the results 
of which are still under analysis. 
7.5.1 The influence of orexin on adult neurogenesis and sleep regulation  
Sleep is required for memory consolidation (Walker and Stickgold, 2004) and disturbed 
sleep results in cognitive deficits (Muzur et al., 2002). Sleep deprivation decreases 
adult neurogenesis (Guzman-Marin et al., 2005, Mirescu et al., 2006). Four days of 
selective REM sleep deprivation contributes to reduction of neurogenesis in the hippo-
campal dentate gyrus. Cell proliferation was reduced, when animals were woken up 
automatically when the EEG indicated REM sleep. These findings support a hypothesis 
that REM sleep-associated processes facilitate proliferation of granule cells in the adult 
hippocampal dentate gyrus (Guzman-Marin et al., 2008). Rapid transitions into REM 
sleep are seen in narcoleptics. This phenomenon occurs because, the weakened 
arousal influence and increased activity of the extended VLPO in the absence of an 
excitatory orexin input would allow earlier and more frequent transitions to the REM 
state (Saper et al., 2001). As the lack of orexin is associated with frequently occurring 
episodes of REM sleep it can be considered that proliferation of neural progenitors may 
be increased by yet unidentified mechanisms associated with this sleep stage. 
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Sleep displays a clear circadian or daily rhythm that is governed by an endogenous 
biological clock located in the suprachiasmatic nucleus of the hypothalamus 
(Mistlberger et al., 1983). Therefore, if sleep plays a direct role in adult neurogenesis, a 
daily rhythm in cell proliferation and expression of neurogenic markers that parallels the 
sleep–wake rhythm might be expected (Meerlo et al., 2009). Under the inhibitory influ-
ence of VLPO cells with a defined circadian rhythm it may be assumed that orexin neu-
rons and thus adult neurogenesis show a circadian activity pattern as well. Conse-
quently, one would expect increased neurogenesis at nighttime in phases of low orexin 
levels. A number of studies have dealt with the question whether a daily rhythm exists 
in hippocampal cell proliferation. Two studies have reported that under baseline condi-
tions the number of proliferating cells in the SGZ of the dentate gyrus is independent of 
the time of day (Kochman et al., 2006, van der Borght et al., 2006). However, another 
study showing that restricted access to a running wheel for 3 h at different times of day 
increased cell proliferation, cell survival, and the total number of new neurons only in 
animals that had wheel access during the middle of the active phase (Holmes et al., 
2004). These data suggest that the influence of exercise on cell proliferation and neu-
rogenesis is modulated by both circadian phase and the amount of daily exercise. The 
question whether adult neurogenesis is under the influence of a circadian rhythm re-
mains open. However, with regard to the effects of orexin on adult neurogenesis and 
sleep new research opportunities arise.  
7.5.2 Implications of the current study results on clinical treatment with 
orexin antagonists 
As mentioned above orexin plays a critical role in the maintenance of wakefulness by 
regulating function of monoaminergic and cholinergic neurons that are implicated in the 
regulation of sleep-wake-cycle. These findings have encouraged the pharmaceutical 
industry to develop drugs targeting orexin receptors as novel medications of sleep dis-
orders, such as insomnia.  
Suvorexant (Merck, Germany) is a potent non-selective (dual) antagonist for both orex-
in receptors (Cox et al., 2010). It has been shown, that patients taking the drug fell 
asleep faster and slept longer than those on placebo (Hopkins, 2012). It was approved 
for sale by the U.S. Food & Drug Administration in August 2014 for the treatment of 
primary insomnia. Thus, the discovery of the critical role of orexin in the regulation of 
sleep/wakefulness has opened the door for a new era of sleep medicine (Mieda and 
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Sakurai, 2013). Theoretical side effects can be considered with regard to the present 
results of the influence of orexin on the adult neurogenesis (see below).  
Recent studies have shown that orexin is involved into modulation of motivated behav-
ior for drugs of abuse as well as natural rewards. In self-administration studies, the 
orexin 1 receptor antagonist SB-334867 attenuated operant responding for high-fat 
pellets, sucrose pellets and ethanol, but not cocaine. Demonstrating that signaling at 
orexin receptors is necessary for reinforcement of specific rewards (Cason et al., 
2010). Thus, it is expected that in the future, orexin antagonists may also be used in 
the therapy of addiction.   
With regard to the present experiments with rodents, the influence of orexin on adult 
neurogenesis might also be relevant in humans. Our results indicate that increased 
adult neurogenesis could occur in patients taking continuously orexin antagonists. 
Considering the functions of adult neurogenesis described above, patients with short- 
to long-term treatment should be examined on whether they are less prone to depres-
sive symptoms, develop a better sense of smell or improve pre-existing memory diffi-
culties.  
7.6 Outlook 
The results of this study suggest a suppressive action of orexin on adult neural stem 
cell proliferation. It remains unclear if orexin acts directly on the progenitor cells within 
the HC and SVZ or indirectly through other neurotransmitters and their systems (e.g. 
noradrenalin, serotonin and dopamine). In addition, the influence via inflammatory me-
diators seems to be possible. Further studies have to be initiated to clarify the nature of 
this interaction. 
Further research is needed to substantiate the supposed antiproliferative effect of orex-
in. To prove the hypothesis the effect of orexin on adult neurogenesis could be exam-
ined in a dose-dependent manner. Orexin/ataxin-3 mice should be investigated at dif-
ferent time points from birth on up to 12 weeks, when already 99 % of orexin neurons 
are lost. With increasing reduction of orexin neurons, a concomitant increase in adult 
neurogenesis could be expected. In an additional experiment orexin/ataxin-3 mice may 
be treated by administration of orexin agonists. If the anti-proliferative effect disap-
pears, it is very likely that the effect is caused by orexin. A parallel study with orexin 
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knock out mice (unpublished data) might additionally support the evidence of an anti-
proliferative effect of orexin.  
Furthermore, it should be investigated whether the anti-proliferative effect of orexin has 
functional relevance on memory and behavior of the affected animals. Results of be-
havioral experiments with orexin/ataxin-3 mice in a parallel study might clarify this 
point. The relationship between orexin-mediated effects on sleep and the circadian 
rhythm on adult neurogenesis appears to be another interesting aspect of future re-
search. The influence of orexin on the balance of newly born and dying progenitor cells 
should be also included in following studies. A study design with an experimental de-
pletion of noradrenergic, serotonergic or dopaminergic systems in the orexin/ataxin-3 
mice would be an interesting approach to make a statement about the significance of 
indirect effects mediated via these neurotransmitters.  
7.7 Final summary 
We found a significantly higher proliferation of stem/precursor cells in the orexin/ataxin-
3 mice in both neurogenic regions, the SGZ and the SVZ. Also in the RMS, higher lev-
els of newly built cells in the orexin/ataxin group were found, but these differences were 
not significant. We were able to demonstrate a significantly higher survival of newly 
built cells in the granular zone, but not for the periglomerular zone of the OB in the 
orexin/ataxin group. A tendency for higher survival rates could be shown for the HC of 
the orexin/ataxin-3 mice. By triple staining we could show that the proportion of newly 
born neurons relative to the total number of newly built cells in the HC was significantly 
higher with 90 % in the orexin-ataxin group compared to 83 % in the control group. In 
both the granular zone and the periglomerular zone of the OB, over 90 % of the total 
amount of new built cells differentiated into neurons in both groups. Also the rate of 
differentiation into a dopaminergic phenotype of the newly born neurons in the peri-
glomerular zone of the OB was not significantly changed with 93 % in the orexin/ataxin-
3 mice compared to 91 % in the WT mice. Together, these observations lead to the 
assumption that orexin suppresses the proliferation of adult NSC, affects the survival 
rate in the OB negatively and hinders the differentiation of newly built cells into neurons 
in the HC.  
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